<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Urinary diversion and reconstruction following cystectomy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Urinary diversion and reconstruction following cystectomy</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Urinary diversion and reconstruction following cystectomy</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shahrokh F Shariat, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bernard H Bochner, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Timothy F Donahue, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Eugene J Pietzak, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Seth P Lerner, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jerome P Richie, MD, FACS</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wenliang Chen, MD, PhD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 08, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Removal of the bladder (cystectomy) is required to treat certain malignant (eg, bladder, colorectal cancer) or nonmalignant conditions (eg, congenital anomaly, trauma, neurologic disorders) [<a href="#rid1">1-3</a>]. After cystectomy, urine needs to be redirected with a urinary diversion and reconstruction procedure.</p><p>Ureterosigmoidostomy, which relied upon the anal sphincter for continence, was the first widely used surgical technique of urinary diversion. Its usefulness, however, was limited by deterioration of renal function over time, metabolic complications, and the development of secondary sigmoid colon cancers. (See <a class="local">'Complications'</a> below.)</p><p>Newer urinary diversion techniques, including continent cutaneous diversions and internal reservoirs connected to the native urethra, have improved quality of life and patient acceptance by permitting volitional voiding. Earlier patient acceptance of radical cystectomy in the natural history of bladder cancer may ultimately improve the outcome of bladder cancer treatment [<a href="#rid4">4</a>]. </p><p>This topic discusses the three reconstructive options most widely used after cystectomy, ileal conduit, continent cutaneous diversion, and orthotopic neobladder. The management of bladder cancer is discussed separately, as are the techniques of radical cystectomy:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2978.html" rel="external">"Overview of the initial approach and management of urothelial bladder cancer"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2974.html" rel="external">"Radical cystectomy"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">RECONSTRUCTIVE OPTIONS</span></p><p class="headingAnchor" id="H3808186328"><span class="h2">Conduits and reservoirs</span><span class="headingEndMark"> — </span>In urinary diversion, a conduit or a continent reservoir is required to replace the bladder and provide an internal reservoir or facilitate transit of urine to an external appliance. The ideal characteristics of a urinary reservoir are listed in the following table  (<a class="graphic graphic_table graphicRef54033" href="/d/graphic/54033.html" rel="external">table 1</a>). </p><p>Urinary conduits and reservoirs are typically constructed from an isolated segment of bowel. In theory, any segment of bowel can be used to form a urinary diversion. However, there are metabolic consequences to using each bowel segment, determined by its absorptive function [<a href="#rid5">5-21</a>]. While most metabolic abnormalities are clinically subtle, they may assume significance in patients with renal insufficiency and in adolescents and young adults who will be subjected to the metabolic abnormalities for a prolonged period. (See <a class="local">'Nutritional and metabolic abnormalities'</a> below.)</p><p>The most commonly used bowel segments in urinary diversions include the distal ileum and/or cecum and the ascending or sigmoid colon; these sites are associated with the fewest metabolic consequences. </p><p>The primary indications for the use of various bowel segments and the associated metabolic consequences and symptomatology are shown in the following table  (<a class="graphic graphic_table graphicRef63267" href="/d/graphic/63267.html" rel="external">table 2</a>) [<a href="#rid19">19,22-25</a>]. In addition, the length and location of the segment used can affect the patient's postoperative bowel function. </p><p class="headingAnchor" id="H2488817604"><span class="h2">Reconstructive techniques</span><span class="headingEndMark"> — </span>Urinary diversion procedures following cystectomy fall into two general categories: incontinent diversions and continent reconstructions.</p><p class="bulletIndent1"><span class="glyph">●</span>Incontinent urine diversion simply directs urine from the ureters through a segment of isolated bowel to the surface of the abdominal wall via a cutaneous stoma. There, urine drains continuously and is collected by an external appliance adhered to the skin surface [<a href="#rid26">26</a>]. The most common type of incontinent urinary diversion is an ileal conduit. (See <a class="local">'Ileal conduits'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>By contrast, continent reservoirs collect and store urine internally and empty stored urine intermittently by catheterization via a cutaneous stoma or volitional voiding. The patient is thereby freed from the need for an external appliance. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A continent cutaneous diversion creates a low-pressure reservoir from a bowel segment and connects it to the skin via a continent channel. The patient empties the urine by self-catheterizing the continent channel. (See <a class="local">'Continent cutaneous diversions'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>By contrast, an orthotopic neobladder connects the bowel segment to the intact urethra. This procedure allows the patient to void volitionally through the urethra, restoring a more natural voiding pattern. (See <a class="local">'Orthotopic neobladders'</a> below.)</p><p></p><p>The process of selecting a particular urinary diversion option is complex and will be presented after each procedure has been described in detail. Factors that should be considered include oncologic (cancer stage and location, urethral margin), surgical (available bowel segment, pelvic radiation, surgeon experience), and patient-related factors (comorbidity, lifestyle, quality of life expectations)  (<a class="graphic graphic_table graphicRef75096" href="/d/graphic/75096.html" rel="external">table 3</a>). (See <a class="local">'Procedural selection'</a> below.)</p><p class="headingAnchor" id="H3"><span class="h1">ILEAL CONDUITS</span><span class="headingEndMark"> — </span>Ileal conduits were the gold standard for urinary reconstruction before the advent of continent diversions [<a href="#rid27">27</a>]. Due to the relative ease of their formation and the shorter operative time, ileal conduits are often used in patients with significant medical comorbidities to minimize postoperative complications and the risk of reoperation. Ileal conduits remain the procedures of choice for many patients, especially those with a shorter life expectancy and those who cannot complete the necessary rehabilitation process to learn how to manage a continent diversion. </p><p class="headingAnchor" id="H672038564"><span class="h2">Techniques of ileal conduit</span><span class="headingEndMark"> — </span>An ileal conduit serves as a method for urine to drain to the exterior. A segment of ileum is selected; the terminal 10 to 15 cm of ileum at the ileocecal junction is typically preserved to maintain adequate absorption of bile salts, vitamin B12, and fat-soluble vitamins. The isolated segment of ileum is exteriorized through the abdominal wall as a stoma, around which an appliance is secured to collect urine. The presence of the stoma and appliance can affect a patient's body image. </p><p>Patients with obesity may require a loop-type (Turnbull) stoma because a short bowel mesentery and thick abdominal wall may prevent the creation of an end-on stoma without undue tension [<a href="#rid28">28</a>].</p><p class="headingAnchor" id="H4"><span class="h2">Outcomes of ileal conduit</span><span class="headingEndMark"> — </span>Ileal conduits have been used for decades since the first report in 1950 by Bricker [<a href="#rid26">26</a>], and therefore detailed information is available regarding the incidence of complications [<a href="#rid27">27,29,30</a>]. Despite the fact that ileal conduits are often performed for patients with significant medical comorbidities, the complication rates are comparable to those of continent diversions performed for generally healthier patients  (<a class="graphic graphic_table graphicRef63297" href="/d/graphic/63297.html" rel="external">table 4</a>). </p><p>The outcomes of ileal conduits are best illustrated by a series of 412 patients followed for a median of 98 months; the frequency of complications ranged from 45 percent at five years to 94 percent at greater than 15 years [<a href="#rid27">27</a>]. The overall rate of complications associated with conduits is similar for ileum and colon segments among properly selected patients [<a href="#rid27">27,31,32</a>]. The most frequent complications are renal insufficiency, stomal problems, bowel problems, urinary tract infections, ureteral obstruction, and urinary calculi (in 27, 24, 24, 24, 14, and 9 percent, respectively) [<a href="#rid27">27</a>]. </p><p>Parastomal hernias are another frequent complication after ileal conduit diversion. The incidence varies widely from 12 to 48 percent, depending on the definition used, the length of follow-up, and whether the diagnosis is made clinically or radiographically [<a href="#rid30">30,33,34</a>]. Factors that increase the risk for developing a parastomal hernia include female sex, obesity, low preoperative albumin, and prior abdominal surgery [<a href="#rid34">34</a>]. Approximately 40 percent of patients with clinically apparent parastomal hernias report symptoms, such as difficulties with the ostomy appliance (poor fit, leakage), pain, and incarceration. As subsequent surgical repair of a parastomal hernia has potential morbidity and high rates of hernia recurrence [<a href="#rid35">35</a>], prophylactic mesh placement at the time of ileal conduit creation is being evaluated in several randomized controlled trials and may prove to be a preferred approach to patients at increased risk for parastomal hernia development [<a href="#rid35">35-38</a>]. (See  <a class="medical medical_review" href="/d/html/3691.html" rel="external">"Parastomal hernia"</a> and  <a class="medical medical_review" href="/d/html/129365.html" rel="external">"Prophylactic mesh for ventral incisional hernia prevention"</a>.)</p><p class="headingAnchor" id="H5"><span class="h1">CONTINENT CUTANEOUS DIVERSIONS</span><span class="headingEndMark"> — </span>All continent cutaneous reservoirs rely upon a low-pressure pouch constructed of various detubularized bowel segments and a functional mechanism that connects the reservoir to the skin designed to prevent involuntary urine flow. The most obvious advantage of this type of diversion is the ability to avoid continuous urine drainage with the need for an external appliance. These continent cutaneous diversions require lifelong intermittent clean self-catheterization through the stoma both to empty the reservoir and to irrigate mucous. </p><p>Patient education, motivation, and manual dexterity are required to manage the stoma and perform the necessary self-catheterization successfully [<a href="#rid29">29</a>]. Although continent cutaneous diversions have been largely supplanted by the orthotopic neobladder, this procedure is used when avoidance of an external appliance is desired but the urethra or bladder neck is nonfunctional or involved by tumor. </p><p class="headingAnchor" id="H362477147"><span class="h2">Techniques of continent cutaneous diversions</span><span class="headingEndMark"> — </span>Many technical variations exist based upon the type of valve mechanism constructed and the segment of intestine utilized. Examples include the Kock, Indiana, and Miami pouches [<a href="#rid39">39-41</a>]. The Kock pouch has fallen out of favor due to the technical complexity of constructing the continent nipple valve and a high rate of complications often requiring reoperation. The Indiana and Miami pouches rely on a tapered ileal segment and plicated ileocecal valve to maintain continence.</p><p>Using the in situ appendix as the continence mechanism and catheterizable limb has improved outcomes and lowered major complication rates [<a href="#rid42">42</a>], and it is a pouch design that can be performed in previously radiated patients [<a href="#rid43">43,44</a>]. </p><p>Another modification uses a tubularized segment of terminal ileum as a ureteral substitute to allow a more proximal ureteroenteric anastomosis and avoid the use of distal ureteral segments that may have been within the fields of radiation. The length of the ileal limb can be tailored to achieve a tension-free anastomosis with the proximal left ureter in the retroperitoneum [<a href="#rid45">45</a>]. </p><p class="headingAnchor" id="H6"><span class="h2">Outcomes of continent cutaneous diversions</span><span class="headingEndMark"> — </span>The majority of studies have demonstrated the safety and functional benefits of continent cutaneous diversions, with daytime and nighttime continence rates reported in the range of 90 to 98 percent [<a href="#rid46">46,47</a>].</p><p>However, complication rates can be significant. As an example, among 112 patients receiving a modified Indiana pouch at a single institution, 90 percent experienced one or more complications at 41 months [<a href="#rid48">48</a>]. Incontinence (any leakage) was the most common complication (28 percent) [<a href="#rid48">48</a>]. The reported rates of incontinence vary significantly depending upon the criteria used to define incontinence and the length of follow-up [<a href="#rid29">29,32,48-51</a>]. </p><p>Incontinence with a continent cutaneous diversion can be due to uninhibited pouch contractions, poor pouch compliance, or an incompetent continence mechanism. Pouch urodynamics are helpful in categorizing the cause of the incontinence.</p><p class="bulletIndent1"><span class="glyph">●</span>In patients with a poorly compliant, high-pressure reservoir, an initial trial of anticholinergics is the preferred approach. Refractory cases usually benefit from augmenting the reservoir with a patch of bowel to decrease pressure and increase capacity.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Incompetent continence mechanisms usually require open revision, although minimally invasive approaches, such as injecting bulking agents, are often helpful for mild incontinence.</p><p></p><p>Other frequent and troublesome long-term complications involve the efferent limb and catheterizable stoma. The reported rate of stomal stenosis and difficulty in catheterizing the stoma is 4 to 15 percent [<a href="#rid48">48,51</a>]. Additional problems include stone formation within the pouch and urinary tract infections, which are observed in up to 20 percent of patients. Twenty-one percent required a reoperation, mostly for stomal stenosis [<a href="#rid48">48</a>].</p><p class="headingAnchor" id="H7"><span class="h1">ORTHOTOPIC NEOBLADDERS</span><span class="headingEndMark"> — </span>Orthotopic neobladders are internal reservoirs connected to the native urethra that rely upon the external striated sphincter and a high-capacity, low-pressure reservoir for continence. Because this approach facilitates the restoration of normal self-image by approximating normal voiding, orthotopic neobladders have become the procedure of choice for many patients requiring reconstruction following cystectomy for bladder cancer [<a href="#rid52">52</a>]. </p><p class="headingAnchor" id="H8"><span class="h2">Techniques of orthotopic neobladders</span><span class="headingEndMark"> — </span>Neobladder reservoirs are constructed from a segment of detubularized intestine (usually ileum) and anastomosed to the native urethra. </p><p>Some neobladders (eg, the hemi-Kock) incorporate an antireflux mechanism to limit backflow of urine from the reservoir to the upper urinary tracts. Although this mechanism mimics the normal antireflux apparatus of the native bladder, its requirement is controversial, and most urologists do not perform this mechanism: </p><p class="bulletIndent1"><span class="glyph">●</span>Proponents cite the detrimental upper tract changes seen in patients who are followed for 10 years or longer after ileal conduits or ureterosigmoidostomy, both of which are associated with free reflux of infected urine [<a href="#rid53">53-56</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Opponents question the need for specific antireflux maneuvers for the following reasons:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Long-term complications of reflux with orthotopic neobladders have been predominantly seen in patients who have high-pressure reservoirs. Contemporary neobladder designs ensure low filling pressures.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Voiding pressures within orthotopic neobladders are generated via the Valsalva maneuver and exerted to all of the intra-abdominal contents, including the ureters and renal pelvis. This equal pressure distribution minimizes reflux during voiding. In addition, some neobladder designs (eg, the Studer reservoir) utilize a long isoperistaltic proximal limb, which provides resistance to retrograde flow, thereby providing additional antireflux protection [<a href="#rid57">57,58</a>]. Long-term follow-up of patients with neobladders that do not incorporate an antireflux design have confirmed that reflux-related complications are rare.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ureteral anastomoses that are designed to prevent reflux may lead to a greater risk of complications (eg, ureteroenteric stricture, ischemic fibrosis of the antireflux valve, stone formation from staples used to construct the valve system), which contribute substantially to morbidities, including impaired renal function [<a href="#rid59">59,60</a>]. </p><p></p><p>Orthotopic neobladders were initially limited to men. In women, urethra-sparing orthotopic substitution was thought to be associated with an increased risk of local recurrence and voiding dysfunction. With improved understanding of the female rhabdoid sphincteric (continence) mechanism, however, this approach has become technically feasible and oncologically safe in selected women as well [<a href="#rid61">61</a>]. The selection criteria for orthotopic neobladders are discussed below. (See <a class="local">'General approach'</a> below.)</p><p class="headingAnchor" id="H523833008"><span class="h2">Outcomes of orthotopic neobladders</span><span class="headingEndMark"> — </span>The functional goals of an orthotopic neobladder are to maintain continence during both the day and night and to allow consistent emptying of the neobladder without the need for intermittent catheterization. </p><p>Continence after an orthotopic urinary diversion is dependent upon an intact external urinary sphincter and pelvic floor, adequate functional urethral length, a high-capacity/low-pressure reservoir, and the age of the patient. Attention to neobladder design, careful surgical technique, appropriate patient selection, and patient education all contribute to optimizing functional results [<a href="#rid29">29,62</a>].</p><p class="headingAnchor" id="H2071839973"><span class="h3">Urinary continence</span><span class="headingEndMark"> — </span>Generally speaking, continence continues to improve over the first year after surgery as the capacity and compliance of the neobladder increase [<a href="#rid63">63,64</a>]. The continence rate, however, can vary by day versus night, men versus women, and young versus old: </p><p class="bulletIndent1"><span class="glyph">●</span>Daytime continence with orthotopic diversions is better and typically precedes nighttime urinary control by 6 to 12 months. </p><p></p><p class="bulletIndent1">Daytime continence rates after orthotopic diversions generally exceed 85 to 90 percent at centers of excellence but have been reported to range from 47 to 100 percent depending on the definition of continence and the length of follow-up [<a href="#rid56">56,65-69</a>]. </p><p></p><p class="bulletIndent1">As with daytime control, nocturnal continence is achieved gradually over the first year once the capacity and compliance of the continent diversion increase. Satisfactory nighttime continence rates at one year range between 71 to 80 percent at high-volume centers [<a href="#rid65">65,70,71</a>]. However, many patients still require nighttime protection, as there is no communication between the contractions in the reservoir and the urinary sphincter, due to loss of afferent input from the detrusor to the central nervous system, and no corresponding increase in urethra resistance during filling. Nerve-sparing surgery, when appropriate, is associated with optimal diurnal continence.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In several large series comprised predominantly of men, daytime and nighttime continence rates ranged from 87 to 100 percent and 70 to 95 percent, respectively  (<a class="graphic graphic_table graphicRef70451" href="/d/graphic/70451.html" rel="external">table 5</a>) [<a href="#rid56">56</a>]. In women, daytime continence rates were also very high (75 to 93 percent) at average follow-up durations of 20 to 33 months; nighttime rates were similar to those of men at 72 to 84 percent  (<a class="graphic graphic_table graphicRef82635" href="/d/graphic/82635.html" rel="external">table 6</a>) [<a href="#rid72">72-76</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Continence rates in individuals over age 70 are lower than those in younger patients.</p><p></p><p class="headingAnchor" id="H3814658062"><span class="h3">Voiding dysfunction</span><span class="headingEndMark"> — </span>A meta-analysis of more than 2000 patients showed a 4 to 25 percent rate of intermittent self-catheterization after neobladder diversion for incomplete emptying [<a href="#rid62">62</a>]. Reported causes of incomplete emptying include urethral angulation, elongation of the neobladder neck, the neobladder neck being in a nondependent portion of pouch, an oversized floppy neobladder, a preserved but dysfunctional native bladder neck, denervated proximal urethra, inadequate pelvic floor relaxation during voiding, and ineffective Valsalva straining [<a href="#rid77">77</a>]. </p><p>Inadequate emptying of the neobladder in men is uncommon. In a single-institution series of 655 men, inadequate emptying (defined as a residual volume &gt;100 mL) was observed in 75 cases (11.5 percent) [<a href="#rid77">77</a>]. In 52 patients, this was due to mechanical obstruction, most commonly either benign strictures of the neovesicourethral anastomosis or local tumor recurrence; in 38 of these cases bladder emptying was restored with a local urological procedure, while 14 required some form of long-term catheterization. In the 23 cases without a mechanical obstruction, failure of bladder emptying was dysfunctional, and intermittent or indwelling catheterization was required.</p><p>Women have a higher risk of requiring intermittent catheterization after orthotopic neobladders, ranging from 11 to 70 percent. The increased need for intermittent catheterization (due to urinary retention) in women is thought to be due in part to a posterior prolapse of the neobladder during Valsalva voiding. Urinary retention associated with female neobladders may be minimized if meticulous surgical technique is used to preserve the autonomous nerve fibers to the remnant urethra and omental flaps are used to provide additional support [<a href="#rid78">78</a>]. </p><p class="headingAnchor" id="H14"><span class="h3">Quality of life</span><span class="headingEndMark"> — </span>Comparisons between orthotopic diversion and incontinent cutaneous diversion are limited by inherent selection bias and the lack of validated instruments to measure bladder-cancer-specific health-related quality of life (QOL) [<a href="#rid79">79</a>]. For example, patients undergoing continent diversion report better baseline QOL levels for physical, urinary, and sexual function compared with patients receiving ileal conduit diversions [<a href="#rid80">80</a>].</p><p>Although some reports have noted improvements in various aspects of QOL (eg, body image) using newer reconstructive techniques such as orthotopic neobladder, few formal studies have documented an improvement in overall QOL [<a href="#rid81">81-85</a>]. A systematic overview of 15 published studies (only one prospective, none randomized) examining health-related QOL after radical cystectomy and urinary diversion for bladder cancer found insufficient data to conclude that any one form of urinary diversion was associated with a better QOL [<a href="#rid86">86</a>]. </p><p>Ultimately, diversion type may not be the defining factor in QOL after cystectomy. Instead, other patient, social, or process factors may control long-term outcomes. While orthotopic diversion may provide several QOL benefits for selected patients, psychological adaptation to urinary diversion appears to result in similar QOL states for patients one year after surgery. </p><p>Critically, regardless of the selected urinary diversion type, there is excellent preservation of QOL following cystectomy across multiple domains [<a href="#rid80">80</a>]. Recovery of QOL occurs as early as three months after cystectomy, which provides further support for radical cystectomy as the standard for high-risk bladder cancer [<a href="#rid80">80</a>].</p><p class="headingAnchor" id="H15"><span class="h1">PROCEDURAL SELECTION</span><span class="headingEndMark"> — </span>The primary goals in selecting a urinary diversion are to provide the patient with convenient, low-pressure urinary storage and the best quality of life with the lowest potential for short- and long-term complications. </p><p class="headingAnchor" id="H806587117"><span class="h2">General principles</span><span class="headingEndMark"> — </span>Detailed evaluations of patients' medical, physical, and psychological status, as well as their social support systems, are required prior to selection of the appropriate urinary diversion procedure. The decision requires consideration of surgical, oncologic, medical, and psychosocial issues [<a href="#rid87">87</a>]. </p><p>While patient preference is of the utmost importance, there are some absolute and relative contraindications to the use of various bowel segments and continent urinary reservoirs  (<a class="graphic graphic_table graphicRef74170" href="/d/graphic/74170.html" rel="external">table 7</a>). In addition, patients should be informed that intraoperative findings may dictate a change in the planned form of urinary diversion; these include a foreshortened mesentery or cancer-related issues such as a positive urethral margin or gross extravesical disease precluding a negative surgical margin. </p><p>Even when an orthotopic neobladder is planned, patients should have a stoma site marked preoperatively by an enterostomal therapist if an ileal conduit is the alternative, in case it becomes necessary based upon intraoperative findings.</p><p class="headingAnchor" id="H118415313"><span class="h2">General approach</span><span class="headingEndMark"> — </span>For most patients who require urinary diversion following cystectomy and are candidates for all three procedures, we suggest an orthotopic neobladder [<a href="#rid52">52,63</a>]. In appropriately selected patients, the creation of an orthotopic neobladder obviates the need for an external stoma and preserves body image without compromising cancer surgery. The patient needs to be fully educated about the necessary commitment to the rehabilitation process and needs to possess adequate manual dexterity to perform self-catheterization, if that becomes necessary.</p><p>The contraindications for orthotopic neobladder include [<a href="#rid88">88</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Insufficient bowel segment length.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inability to perform self-catheterization. (See <a class="local">'Psychosocial and medical considerations'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inadequate renal or hepatic function (eg, estimated glomerular filtration rate [eGFR] &lt;45 mL/min/1.73 m<sup>2</sup>). (See <a class="local">'Psychosocial and medical considerations'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cancer at the urethral margin. (See <a class="local">'Urethral margin'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intractable urethral stricture.</p><p></p><p>A continent cutaneous diversion may still offer substantial advantages over an incontinent ileal conduit for patients who desire to avoid a stomal appliance but are not candidates for an orthotopic neobladder due to tumor involvement of the urinary outflow tract or who do not desire an orthotopic neobladder. Candidates for a continent cutaneous reservoir should be willing and able to self-catheterize and have sufficient bowel segment length and adequate renal and hepatic function as well.</p><p>From the patient's perspective, one of the primary reasons for choosing an orthotopic neobladder over continent cutaneous diversion is the maintenance of normal body image and function. Conversely, continent cutaneous diversion may offer a significantly better quality of life compared with an orthotopic neobladder with respect to social dryness.</p><p>An ileal conduit is used for the remaining patients who are candidates for neither option of continent diversion. There is no contraindication for an ileal conduit in patients who can tolerate a cystectomy.</p><p>Ileal conduit is the most commonly performed urinary diversion after radical cystectomy worldwide. It is associated with lower morbidity and reoperation rates compared with those of continent diversion options. It is also the procedure of choice for older adults as well as patients with anatomical constraints, poor hepatorenal function, and limited ability to self-catheterize [<a href="#rid89">89</a>]. </p><p class="headingAnchor" id="H16"><span class="h2">Oncologic considerations</span><span class="headingEndMark"> — </span>The primary goal of cystectomy for bladder cancer is control of the underlying tumor, and every effort must be made to avoid compromising the effectiveness of the resection. Disease extent and anatomic considerations can limit reconstructive options.</p><p class="headingAnchor" id="H563692284"><span class="h3">Urethral margin</span><span class="headingEndMark"> — </span>Preservation of the urethra in patients with urothelial tumors in order to construct an orthotopic neobladder raises concerns about possible recurrence of cancer, since the transitional cell lining of the urethra may be particularly susceptible to the development of new tumors in these patients. (See <a class="local">'Recurrent urothelial cancer'</a> below.)</p><p>Creation of an orthotopic neobladder requires that the urethra be free of cancer. We recommend performing an intraoperative pathologic assessment of the distal urethral margin at the time of surgery (frozen section) before proceeding with an orthotopic neobladder, rather than relying upon preoperative criteria to predict urethral recurrence [<a href="#rid88">88,90</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>For men, intraoperative frozen section assessment of the urethral margin is required, even if the preoperative evaluation was negative. Transurethral prostatic biopsy was previously performed to assess prostatic urethral involvement prior to construction of an orthotopic neobladder [<a href="#rid91">91</a>]. However, biopsy results do not always correlate with final histology [<a href="#rid92">92,93</a>]. Furthermore, although microscopic involvement of the prostatic urethra may be predictive of a higher rate of urethral recurrence, lower-than-expected urethral recurrence rates have been observed in orthotopically reconstructed patients despite involvement of the prostate. Thus, routine preoperative prostatic biopsies are generally not required, although this can be the surgeon's preference [<a href="#rid94">94</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In women, creation of an orthotopic neobladder is contraindicated when there is overt involvement of the urethra. Tumor involvement of the bladder neck or invasion of the anterior vaginal wall is associated with an increased risk of concomitant urethral involvement, often representing an absolute contraindication to an orthotopic diversion [<a href="#rid95">95-99</a>]. Such patients should be excluded from orthotopic diversion; however, select women with a negative full-thickness frozen section of their urethral margin can be safely reconstructed to the urethra [<a href="#rid100">100</a>].</p><p></p><p class="headingAnchor" id="H249169562"><span class="h3">Locally advanced disease</span><span class="headingEndMark"> — </span>Locally advanced bladder cancer and/or regional node-positive disease used to be an absolute contraindication to a continent diversion. The concerns were having to treat a local recurrence and giving chemotherapy and radiation therapy to patients with a urinary reservoir. </p><p>The contemporary view is that orthotopic urethral diversions and continent cutaneous diversions can be used in selected patients with regional metastases or locally advanced disease as few such patients will experience complications that would disrupt neobladder function [<a href="#rid65">65,101</a>]. </p><p>The dwell time of urine in the reservoirs during chemotherapy is a concern and can cause toxicity due to the risk of <a class="drug drug_general" data-topicid="9630" href="/d/drug information/9630.html" rel="external">methotrexate</a> absorption with methotrexate vinblastine <a class="drug drug_general" data-topicid="9391" href="/d/drug information/9391.html" rel="external">doxorubicin</a> <a class="drug drug_general" data-topicid="9271" href="/d/drug information/9271.html" rel="external">cisplatin</a> (MVAC) treatment [<a href="#rid102">102</a>]. This issue has generally been managed by the use of an indwelling catheter during the chemotherapy infusion along with increased hydration [<a href="#rid103">103</a>]. Placement of an indwelling catheter in reservoirs during aggressive hydration required for receiving cisplatin can also avoid the risk of specific issues related to the reservoir, such as overdistension or rupture. </p><p>Data are limited regarding the proportion of patients in whom adjuvant chemotherapy is delayed by postoperative complications. However, neoadjuvant, rather than adjuvant, chemotherapy is generally used in patients with muscle-invasive bladder cancer because of a survival benefit [<a href="#rid104">104</a>]. (See  <a class="medical medical_review" href="/d/html/2966.html" rel="external">"Adjuvant therapy for muscle-invasive urothelial carcinoma of the bladder"</a> and  <a class="medical medical_review" href="/d/html/2991.html" rel="external">"Neoadjuvant treatment options for muscle-invasive urothelial bladder cancer"</a>.)</p><p class="headingAnchor" id="H1987515029"><span class="h2">Minimally invasive urinary diversion</span><span class="headingEndMark"> — </span>Minimally invasive approaches for radical cystectomy are increasingly being adopted at some centers [<a href="#rid105">105-107</a>]. While all minimally invasive radical cystectomies are performed laparoscopically or robotically, the urinary diversion portion of the procedure can be performed either extracorporeally or intracorporeally due to time and technical constraints. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Extracorporeal diversion</strong> – To date, most randomized trials comparing open with robotic cystectomies have used extracorporeal diversions through a mini-laparotomy and have shown similar short-term complication rates and oncologic outcomes [<a href="#rid108">108-110</a>]. When constructing an extracorporeal urinary diversion, it is important to maintain a robust blood supply to the ureters to minimize the risk of ureteroenteric strictures [<a href="#rid111">111,112</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intracorporeal diversion</strong> – As more surgeons become comfortable with robotic cystectomy, there is increasing interest in performing intracorporeal urinary diversions [<a href="#rid113">113</a>]. The iROC trial reported that a robotic-assisted radical cystectomy with a completely intracorporeal urinary diversion had some short-term benefits over open cystectomy, including 2.2 (95% CI 0.50-3.85) fewer days in the hospital in the first 90 days, less blood loss, fewer wound complications and venous thrombotic events, and better quality of life scores at up to 12 weeks [<a href="#rid114">114</a>]. </p><p></p><p>With the growing popularity of minimally invasive radical cystectomy, there is also concern that patients who would otherwise be excellent candidates for (open) continent urinary diversions have instead been treated with intracorporeal incontinent diversions [<a href="#rid115">115</a>]. A completely intracorporal approach to both neobladder urinary diversions [<a href="#rid116">116</a>] and cutaneous catheterizable pouches [<a href="#rid117">117</a>] are feasible but present a technically challenging operation. </p><p class="bulletIndent1"><span class="glyph">●</span>A single-center randomized controlled trial of open versus robotic radical cystectomy with extracorporeal diversion reported use of orthotopic neobladder urinary diversion in 55 percent of patients in each arm of the trial [<a href="#rid118">118</a>]. By contrast, in the iROC trial, only 12 percent (19 of 161) in the robotic intracorporeal urinary diversion and only 10 percent (16 of 156) in the open group underwent a continent/neobladder diversion [<a href="#rid114">114</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>While the National Cancer Database demonstrated increasing utilization of minimally invasive approaches for radical cystectomy, the American College of Surgeons National Surgical Quality Improvement Program has shown that utilization of orthotopic neobladder has decreased over time, with now fewer than 20 percent of patients receiving an orthotopic neobladder [<a href="#rid119">119</a>]. Similarly, European countries have also reported declining rates in the utilization of orthotopic neobladder from 33 percent in 2006 to 27 percent by 2014 [<a href="#rid120">120</a>]. </p><p></p><p>While intracorporeal continent urinary diversions have been routinely performed by high-volume robotic bladder cancer surgeons, for less experienced surgeons, performing radical cystectomy robotically should not come at the expense of selecting an incontinent diversion for a patient who is a reasonable continent diversion. Thus, it is critical that surgeons performing robotic cystectomy continue to offer continent urinary diversions to appropriate candidates regardless of whether they perform the diversion through an intracorporeal or extracorporeal after a robotic cystectomy or opt for an open cystectomy with urinary diversion.</p><p class="headingAnchor" id="H17"><span class="h2">Diversion after pelvic radiation therapy</span><span class="headingEndMark"> — </span>Precystectomy pelvic radiation therapy (RT) was formerly thought to impair functional outcomes (particularly continence) and increase postoperative complications (eg, wound infections, ureteroileal anastomotic leaks) from urinary diversions. These concerns arose from earlier reports of a high incidence of serious complications following salvage cystectomy after failure of primary RT for bladder cancer [<a href="#rid121">121,122</a>]. </p><p>However, more contemporary studies support the feasibility of continent urinary diversions in irradiated patients [<a href="#rid123">123</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>In a retrospective series of 86 patients undergoing continent cutaneous diversion with Kock pouch, 44 of whom were previously irradiated, there were no significant differences between irradiated and nonirradiated patients with respect to operative time, intraoperative blood loss, or transfusion requirements [<a href="#rid124">124</a>]. The irradiated group had eight urine leaks (20 percent) with three requiring surgical repair, while the control group had five urine leaks (12 percent) with one requiring repair.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a cohort of 18 patients who underwent cystectomy and orthotopic neobladder after pelvic RT, daytime and nighttime continence rates were only 67 and 56 percent, respectively [<a href="#rid125">125</a>]. However, for those with persistent postoperative incontinence, placement of an artificial urethral sphincter successfully restored complete voiding control in all patients with incontinence.</p><p></p><p>For patients who have had prior radiation therapy, careful attention should be paid to the character, viability, and vascularity of the tissues, particularly the ureters and urethra. The bowel segment to be used for diversion may need to be selected based upon intraoperative findings of irradiated bowel segments. Although the transverse colon has historically been used as a conduit in patients with prior pelvic radiation, there is still risk of ureteral-colonic stricture development [<a href="#rid126">126</a>]. Experience has shown that the ileum can be safely used in carefully selected patients [<a href="#rid127">127</a>]. Orthotopic neobladder reconstruction can also be performed with reasonable functional outcomes at experienced centers [<a href="#rid125">125,128</a>].</p><p>Radiation-induced blood vessel damage can result in ureteral stricture rates as high as 32 percent, prolonged incontinence in up to 44 percent of neobladder reconstructions, stomal stenosis in up to 39 percent of catheterizable channels, and fistulas in up to 7 percent [<a href="#rid125">125,129,130</a>]. Reoperation is required to address these complications in 8 to 69 percent of patients; the most common reasons for reoperation include stomal revisions, ureteral anastomotic revisions, and procedures to correct incontinence and repair of fistulas [<a href="#rid125">125,129</a>].</p><p class="headingAnchor" id="H19"><span class="h2">Psychosocial and medical considerations</span><span class="headingEndMark"> — </span>The choice of urinary diversion has a significant impact on the long-term health-related quality of life for patients who undergo radical cystectomy, and each type of diversion is associated with its own unique set of advantages and disadvantages. Thus, clinicians must first determine if a patient is a candidate for each diversion option and counsel the patient on all feasible options. Only then should an option be selected based upon the patient's values and preferences. Multiple factors need to be considered when choosing the appropriate procedure for an individual patient:</p><p class="bulletIndent1"><span class="glyph">●</span>The patient and caretaker should have realistic expectations about the outcome associated with each reconstruction option. They also need to understand the efforts that will be required on their part during the rehabilitation process. In addition, patients need to have sufficient manual dexterity to master self-catheterization if the decision is made to proceed with a continent diversion. In particular, women who desire a neobladder need to have manual dexterity given the risk of urinary retention. In addition to the clinician, the enterostomal nurse specialist can be invaluable in educating the patient and caretaker and assisting with the decision-making process [<a href="#rid131">131</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Advanced age can complicate both the procedure and the rehabilitation process. However, physiologic age is more relevant, and no formal cutoff should be applied. Older patients need to be aware that recovery of continence may take longer than in younger patients. Nonetheless, the ultimate results seem to be similar to those achievable in younger patients [<a href="#rid132">132,133</a>]. Our policy is to offer orthotopic neobladder and continent cutaneous diversion to older patients if they are healthy and motivated enough to care for the diversion. If an older patient subsequently becomes unable to care for the continent diversion, then an indwelling Foley catheter may be placed into the diversion, similar to what might be done for the native bladder.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Obesity increases the technical difficulty of cystectomy and may complicate orthotopic neobladder construction [<a href="#rid134">134</a>]. However, the postoperative management of an ileal loop conduit or a continent reservoir is also more difficult in patients with obesity, and most surgeons do not consider obesity to be a contraindication to reconstruction with an orthotopic neobladder [<a href="#rid135">135</a>]. Many, including the authors, feel that reconstruction to the urethra may be the least complicated reconstructive option for patients with obesity. However, obesity may be associated with a higher incidence of a thickened, foreshortened mesenteric root, which can preclude the ability to anastomose an orthotopic urinary diversion to the native urethra.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Adequate renal function is required for the creation of any continent diversion. Urinary excretion products are resorbed through the mucosal surface, imposing an extra metabolic burden on the kidneys. Typically, only mild metabolic abnormalities will be observed in patients who have normal renal function. For those with more severe renal dysfunction with serum creatinine values &gt;2.0 to 2.5 mg/dL (180 to 230 microM/L), or an eGFR rate of &lt;45 mL/min/1.73 m<sup>2</sup>, an ileal conduit is preferred over other approaches. (See <a class="local">'Impaired renal function'</a> below.) </p><p></p><p class="headingAnchor" id="H20"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>Reported early and long-term morbidity rates following urinary diversions range between 20 to 56 percent within the first 30 days after surgery, and from 28 to 94 percent beyond 30 days [<a href="#rid27">27,49,136</a>]. </p><p>When using strict reporting criteria, as many as 64 percent of patients will experience a complication within 90 days of their radical cystectomy, including 67 percent during the operative hospital admission and 58 percent following discharge [<a href="#rid137">137</a>]. The most common complications are gastrointestinal complications (29 percent), followed by infectious complications (25 percent) and wound-related complications (15 percent) [<a href="#rid137">137</a>]. </p><p>Diversion-related complications are specific to the type of diversion and are generally categorized into those involving the bowel anastomosis, those related to the type of reservoir/conduit, and those associated with the ureterointestinal anastomosis [<a href="#rid29">29</a>]. The complications seen with continent urinary diversions also differ by the time of occurrence (early versus long-term)  (<a class="graphic graphic_table graphicRef76468" href="/d/graphic/76468.html" rel="external">table 8</a>) [<a href="#rid29">29,32,48-51</a>]. If one combines the reported percentage of early and late complications in large institutional series associated with each procedure, the risk of having a significant complication over the lifetime of the patient is approximately 8 to 10 percent for orthotopic neobladders and 18 to 38 percent for continent cutaneous reservoirs.</p><p>Complications unique to a particular type of diversion have been discussed in the appropriate sections above. Complications common to most or all types of diversions are further discussed below. </p><p class="headingAnchor" id="H3682680232"><span class="h2">Infection</span><span class="headingEndMark"> — </span>Infectious complications can contribute to acute morbidity and chronic renal insufficiency. Among the contributory factors are the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Intestinal segments that are used to fashion the reservoir/conduit are normally colonized with bacteria [<a href="#rid138">138</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Incomplete voluntary voiding may leave residual urine, a nidus for infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intermittent catheterization may introduce bacteria into the reservoir in a retrograde manner, especially if it is done carelessly.</p><p></p><p>After urinary diversion, patients do not require chronic suppressive antibiotic therapy unless there is a history of recurrent infections. Although the presence of small bowel intestinal mucosa appears to promote asymptomatic bacterial colonization, urosepsis rarely occurs unless the patient has recurrent urinary tract infections. This was illustrated in a series of 66 patients with orthotopic neobladders [<a href="#rid139">139</a>]. Asymptomatic bacteriuria was seen in 78 percent of the 55 patients who voided through an orthotopic neobladder, while only 39 percent developed urinary infection, and urosepsis rarely occurred, except in the context of recurrent urinary tract infections. </p><p class="headingAnchor" id="H23"><span class="h2">Impaired renal function</span><span class="headingEndMark"> — </span>Progressive impairment of renal function over time is observed in some patients after urinary diversion. The development of urinary tract obstruction (at the site of either ureteral implantation or reservoir/conduit outflow), stones, and chronic infection are contributory factors. Careful surveillance for evidence of obstruction or stone formation and treatment of infection will allow for prompt intervention, which may prevent or minimize loss of renal function. </p><p>The most extensive data on clinically important impaired renal function come from a Surveillance, Epidemiology, and End Results (SEER) Medicare database study of a cohort of 4015 patients with normal renal function and no hydronephrosis who underwent radical cystectomy between 1992 and 2010, in which 84 percent were reconstructed with an ileal conduit and 16 percent with a continent diversion [<a href="#rid140">140</a>]. End-stage kidney disease developed in 7 percent of patients; the estimated risks of developing end-stage kidney disease at 5 and 10 years were 8 and 17 percent, respectively. </p><p>On multivariate analysis, the risk of developing end-stage kidney disease was not associated with whether patients had an ileal conduit or a continent diversion (hazard ratio 1.06, 95% CI 0.78-1.44). Neither was the choice of urinary diversion independently associated with decreased renal function (measured by estimated glomerular filtration rate) in other studies [<a href="#rid141">141,142</a>]. </p><p>Absorption of urinary contents in a patient with renal insufficiency can result in chronic acidosis and in osteopenia/osteoporosis from mobilization of phosphate stores. Because ileal conduits have less contact time with urine compared with continent diversion options, they are preferred in patients with existing renal insufficiency. (See <a class="local">'General approach'</a> above.)</p><p class="headingAnchor" id="H25"><span class="h2">Nutritional and metabolic abnormalities</span><span class="headingEndMark"> — </span>Exclusion of an ileal or colonic segment of bowel may result in malabsorption of bile salts and vitamin B12.</p><p class="bulletIndent1"><span class="glyph">●</span>Extensive ileal resection can lead to lipid malabsorption and gallstone formation secondary to the loss of bile salts, which are absorbed in the terminal ileum. However, the ileal segments used for urinary reconstruction are generally short enough to avoid this problem [<a href="#rid19">19</a>]. In one study, 10 percent of men and 25 percent of women developed gallstones at a mean follow-up of 41 months after urinary diversion; these incidences were comparable to those seen in the American general population [<a href="#rid143">143</a>]. Excess loss of bile salts can also lead to chronic diarrhea. (See  <a class="medical medical_review" href="/d/html/662.html" rel="external">"Gallstones: Epidemiology, risk factors and prevention", section on 'Prolonged fasting/parenteral nutrition'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Vitamin B12 is primarily absorbed by the ileum. Thus, if an ileal segment is used for the urinary diversion, B12 deficiency can develop [<a href="#rid19">19</a>]. The true incidence of B12 deficiency that develops as a result of urinary diversion is unknown; long-term estimates range from 0 to as high as 33 percent five years after urinary reconstruction [<a href="#rid56">56,65</a>]. Periodic monitoring of B12 levels should be considered in all patients who undergo urinary diversion using the terminal ileum, particularly long-term survivors [<a href="#rid144">144,145</a>]. The authors recommend that B12 levels be monitored annually beginning three to five years following diversion and that patients be evaluated and treated for symptoms consistent with B12 deficiency. (See  <a class="medical medical_review" href="/d/html/7153.html" rel="external">"Causes and pathophysiology of vitamin B12 and folate deficiencies", section on 'Small intestinal inflammation or surgery'</a>.) </p><p></p><p>The use of any bowel segment for a reservoir or conduit can cause metabolic abnormalities through the resorption of urinary metabolites via the intestinal mucosa [<a href="#rid19">19</a>].</p><p>Hyperchloremic metabolic acidosis can result from resorption of excreted metabolites through the intestinal mucosa of the diversion. Severe acidosis was a major problem following ureterosigmoidostomy but is less so with modern reconstructions using ileum and colon that have reduced contact between urine and bowel mucosa [<a href="#rid19">19</a>]. (See  <a class="medical medical_review" href="/d/html/2320.html" rel="external">"Acid-base and electrolyte abnormalities with diarrhea"</a>.)</p><p>The long-term effects of uncorrected acidosis include osteomalacia from mineral dissolution and stimulation of osteoclasts. Chronic metabolic acidosis can occur in 5 to 13 percent of patients after urinary diversion, but it takes years of uncorrected acidosis before radiographic evidence of bone demineralization develops [<a href="#rid146">146</a>]. Population-based studies suggest that the risk of fractures increases as much as 21 percent following cystectomy and urinary diversion [<a href="#rid147">147</a>]. </p><p>To reduce the likelihood of developing bone sequelae from chronic acidosis, patients with a venous bicarbonate level of less than 21 mmol/L should be considered for supplementation with oral <a class="drug drug_general" data-topicid="9928" href="/d/drug information/9928.html" rel="external">sodium bicarbonate</a> and potentially calcium and vitamin D [<a href="#rid148">148-150</a>]. Regardless of the type of diversion, regular monitoring of electrolytes and acid-base status should occur at both early and late follow-up visits to allow for the institution of appropriate corrective therapy as needed. </p><p class="headingAnchor" id="H26"><span class="h2">Intestinal cancer</span><span class="headingEndMark"> — </span>Bowel segments used to construct urinary diversions are more susceptible to intestinal tumor development than bowel segments in the general population [<a href="#rid151">151</a>]. Chronic exposure to urine causes progressive changes, including relatively thin intestinal epithelium with villous atrophy that initially does not have dysplastic or neoplastic features [<a href="#rid152">152</a>]. </p><p>The risk after an ureterosigmoidostomy (or variants) is higher than after other types of diversions due to the mixing of fecal and urinary stream [<a href="#rid153">153,154</a>]. The pathogenesis of such tumors remains uncertain but may involve a combination of carcinogenic action and mucosal cellular instability at the anastomotic site, leading first to dysplasia and subsequently to carcinoma. With a ureterosigmoidostomy, adenocarcinoma of the conduit develops after a median latency of 26 years [<a href="#rid155">155</a>]. Patients undergoing ureterosigmoidostomy should be given information concerning this risk and should undergo regular colonoscopic surveillance beginning five years after surgery [<a href="#rid156">156,157</a>]. </p><p class="headingAnchor" id="H1793164631"><span class="h2">Reservoir rupture</span><span class="headingEndMark"> — </span>Spontaneous rupture of either a continent cutaneous reservoir or an orthotopic neobladder is rare [<a href="#rid158">158</a>]. Generally, this has been associated with poor compliance with catheterization of a continent cutaneous reservoir or, rarely, with acute or chronic neobladder overdistention.</p><p class="headingAnchor" id="H742837726"><span class="h1">RECURRENT UROTHELIAL CANCER</span><span class="headingEndMark"> — </span>The incidence of urethral recurrence after radical cystectomy ranges from 0.5 to 18 percent [<a href="#rid95">95,159-168</a>]; a meta-analysis including more than 3100 patients described an overall risk of 8 percent [<a href="#rid96">96,167</a>]. </p><p class="headingAnchor" id="H3340560855"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>Risk factors associated with urethral recurrence after radical cystectomy include multifocal disease, carcinoma in situ (CIS), upper tract urothelial carcinoma, and involvement of the bladder neck or prostatic urethra [<a href="#rid95">95,159-171</a>]. </p><p>In men, one of the most important risk factors for urethral recurrence is prostatic stromal invasion [<a href="#rid90">90,92,172,173</a>]. In a study of 436 radical cystectomy patients, the five-year probability of urethral recurrence was 6 percent for patients without prostatic involvement, compared with 15 percent for patients with superficial involvement and 21 percent for those with stromal invasion of the prostate [<a href="#rid95">95</a>]. </p><p>In a study of 235 consecutive patients undergoing radical cystoprostatectomy, 33 percent of specimens had prostatic urothelial carcinoma, of which 64 percent had prostatic stromal invasion [<a href="#rid174">174</a>]. </p><p>However, patients whose urinary stream has been diverted through the urethra have a lower-than-expected recurrence rate, despite the retention of the urethra. In some series, this has been observed even in men with tumor involvement of the prostatic urethra. In one series of 196 men undergoing cystoprostatectomy and orthotopic urinary diversion, only one had a urethral recurrence despite the finding of microscopic involvement of the prostatic urethra in 13 and foci of CIS in 83 [<a href="#rid159">159</a>].</p><p>Thus, although prostate tumor involvement is a risk factor for urethral recurrence, it should not preclude orthotopic diversion, provided that intraoperative frozen section analysis of the urethral margin after radical cystectomy is without evidence of tumor [<a href="#rid88">88,90,160</a>]. (See <a class="local">'Urethral margin'</a> above.)</p><p>Although data are more limited, oncologic outcomes in women appear to be similar to those in men [<a href="#rid4">4,76,175</a>]. As an example, in one series of 145 women with negative margins on frozen section at the time of cystectomy, only two (1.4 percent) developed isolated urethral recurrence [<a href="#rid4">4</a>].</p><p>When patients are properly selected for orthotopic diversion, the risk of urothelial recurrence is small, and close follow-up with prompt intervention for urethral recurrence can result in a good oncologic outcome [<a href="#rid95">95,159-168</a>].</p><p class="headingAnchor" id="H623814475"><span class="h2">Surveillance</span><span class="headingEndMark"> — </span>Most recurrences are apparent within the first two years following cystectomy, although late recurrences have been reported [<a href="#rid95">95,159-171</a>]. Thus, regular follow-up of the retained urethra is indicated.</p><p>We follow patients with a urine cytology using either a voided or urethral wash specimen depending on the diversion, particularly patients at high risk (ie, those with CIS or any prostatic involvement at the time of cystectomy). We also urethroscope any patient with urethral-related symptoms, abnormal discharge, or hematuria.</p><p>However, the utility of surveillance programs (ie, urethral wash cytology) to monitor for urethral recurrence following cystectomy is controversial [<a href="#rid176">176</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Some studies have not demonstrated a difference in clinical outcome in screened patients compared with those followed clinically [<a href="#rid177">177,178</a>]. As an example, in a series of 176 men undergoing cystoprostatectomy with urinary diversion, urethral recurrence was documented in 13 of 48 monitored individuals (10 of whom underwent urethrectomy) and 16 of 128 patients who were followed clinically (all of whom underwent urethrectomy) [<a href="#rid177">177</a>]. There was no difference in the rate of disease progression regardless of the method of diagnosis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>On the other hand, proponents of surveillance argue that earlier diagnosis of an asymptomatic urethral recurrence provides a better chance for curative urethrectomy [<a href="#rid168">168</a>]. A poorer outcome in patients with more advanced urethral recurrences has been demonstrated, strongly supporting the use of techniques to detect recurrent disease at an early stage [<a href="#rid161">161</a>].</p><p></p><p class="headingAnchor" id="H1402021362"><span class="h2">Management of recurrence</span><span class="headingEndMark"> — </span>Urethral recurrence often presents with bloody urethral discharge, pelvic/perineal pain, and/or a mass in the urethra [<a href="#rid95">95,159-168</a>] and can occur up to 20 years after radical cystectomy [<a href="#rid179">179</a>]. </p><p>The management of urethral recurrence after cystectomy is total urethrectomy, including excision of the meatus. Surgical management of these recurrences has limited morbidity, and, when revision of the diversion is indicated, a continent diversion can be maintained [<a href="#rid95">95,159-168</a>]. </p><p>Transurethral management of noninvasive urethral recurrences has been described [<a href="#rid95">95,162</a>]. With proper patient selection, this approach may obviate a more invasive urethrectomy and revision of the urinary diversion. Intraurethral therapy with bacille Calmette-Guerin (BCG) has been described with mixed results [<a href="#rid70">70,164</a>]. (See  <a class="medical medical_review" href="/d/html/2996.html" rel="external">"Treatment of primary non-muscle invasive urothelial bladder cancer"</a>.)</p><p>Patients with urethral recurrence and gross disease on cross-sectional imaging should be considered for systemic chemotherapy. (See  <a class="medical medical_review" href="/d/html/3000.html" rel="external">"Treatment of metastatic urothelial carcinoma of the bladder and urinary tract"</a>.) </p><p class="headingAnchor" id="H3652231872"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/122007.html" rel="external">"Society guideline links: Bladder cancer"</a> and  <a class="medical medical_society_guidelines" href="/d/html/138541.html" rel="external">"Society guideline links: Cystectomy"</a>.)</p><p class="headingAnchor" id="H27"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/d/html/870.html" rel="external">"Patient education: Bladder cancer treatment; muscle invasive cancer (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H28"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Types of urinary diversion after radical cystectomy</strong> – Urinary diversion is required following cystectomy for benign or malignant conditions. Ileal conduit, continent cutaneous diversion, and orthotopic neobladder are the three most commonly used techniques of urinary diversion. (See <a class="local">'Introduction'</a> above and <a class="local">'Reconstructive options'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Ileal conduit</strong> – Ileal conduits are the archetypical procedure of incontinent urinary diversions. Urine is directed from the ureters through a segment of isolated bowel to the surface of the abdominal wall via a cutaneous stoma. There, urine drains continuously and is collected by an external appliance adhered to the skin surface. (See <a class="local">'Ileal conduits'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Continent cutaneous diversion</strong> – Continent cutaneous diversions create a low-pressure reservoir from a bowel segment and connect it to the skin via a continent channel. The patient empties the urine by self-catheterizing the continent channel. (See <a class="local">'Continent cutaneous diversions'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Orthotopic neobladder</strong> – Orthotopic neobladders connect a bowel segment to the intact urethra. This procedure allows the patient to void volitionally through the urethra, restoring a relatively more natural voiding pattern. (See <a class="local">'Orthotopic neobladders'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>How to select a method of diversion procedure</strong> – For most patients who require urinary diversion following cystectomy, we suggest an orthotopic neobladder (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). An orthotopic neobladder obviates the need for an external stoma and preserves the patient's body image without compromising cancer surgery. The patient needs to have sufficient bowel segment length, adequate renal and hepatic reserve, no tumor involvement at the urethral margin or intractable urethral stricture, and the ability to self-catheterize if necessary. (See <a class="local">'General approach'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A continent cutaneous diversion may still offer substantial advantages over an incontinent ileal conduit for patients who desire to avoid a stomal appliance but are not candidates for an orthotopic neobladder due to tumor involvement of the urinary outflow tract or who do not desire an orthotopic neobladder. Patients seeking continent cutaneous diversions should be willing and able to self-catheterize and have sufficient bowel segment length and adequate renal and hepatic function. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>An ileal conduit is used for the remaining patients who are candidates for neither option of continent diversion. There is no contraindication to an ileal conduit in patients who can tolerate a cystectomy. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intraoperative pathologic assessment before orthotopic neobladder construction</strong> – Intraoperative pathologic assessment of the distal urethral margin is recommended at the time of surgery (frozen section) before proceeding with an orthotopic neobladder. Patients should be informed that intraoperative findings may dictate a change in the planned form of urinary diversion. (See <a class="local">'Oncologic considerations'</a> above and <a class="local">'General principles'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Estape R, Mendez LE, Angioli R, Penalver M. Urinary diversion in gynecologic oncology. Surg Clin North Am 2001; 81:781.</a></li><li><a class="nounderline abstract_t">Petros JG, Augustinos P, Lopez MJ. Pelvic exenteration for carcinoma of the colon and rectum. Semin Surg Oncol 1999; 17:206.</a></li><li><a class="nounderline abstract_t">Kaefer M, Tobin MS, Hendren WH, et al. Continent urinary diversion: the Children's Hospital experience. J Urol 1997; 157:1394.</a></li><li><a class="nounderline abstract_t">Ali-el-Dein B, Abdel-Latif M, Ashamallah A, et al. Local urethral recurrence after radical cystectomy and orthotopic bladder substitution in women: a prospective study. J Urol 2004; 171:275.</a></li><li><a class="nounderline abstract_t">Adams MC, Mitchell ME, Rink RC. Gastrocystoplasty: an alternative solution to the problem of urological reconstruction in the severely compromised patient. J Urol 1988; 140:1152.</a></li><li><a class="nounderline abstract_t">Kaveggia FF, Thompson JS, Schafer EC, et al. Hyperammonemic encephalopathy in urinary diversion with urea-splitting urinary tract infection. Arch Intern Med 1990; 150:2389.</a></li><li><a class="nounderline abstract_t">McDougal WS, Koch MO. Accurate determination of renal function in patients with intestinal urinary diversions. J Urol 1986; 135:1175.</a></li><li><a class="nounderline abstract_t">Koch MO, McDougal WS, Flora MD. Urease and the acidosis of urinary intestinal diversion. J Urol 1991; 146:458.</a></li><li><a class="nounderline abstract_t">Koch MO, McDougal WS, Thompson CO. Mechanisms of solute transport following urinary diversion through intestinal segments: an experimental study with rats. J Urol 1991; 146:1390.</a></li><li><a class="nounderline abstract_t">Klein EA, Montie JE, Montague DK, et al. Jejunal conduit urinary diversion. J Urol 1986; 135:244.</a></li><li><a class="nounderline abstract_t">Plawker MW, Rabinowitz SS, Etwaru DJ, Glassberg KI. Hypergastrinemia, dysuria-hematuria and metabolic alkalosis: complications associated with gastrocystoplasty. J Urol 1995; 154:546.</a></li><li><a class="nounderline abstract_t">Nguyen DH, Bain MA, Salmonson KL, et al. The syndrome of dysuria and hematuria in pediatric urinary reconstruction with stomach. J Urol 1993; 150:707.</a></li><li><a class="nounderline abstract_t">Gosalbez R Jr, Woodard JR, Broecker BH, Warshaw B. Metabolic complications of the use of stomach for urinary reconstruction. J Urol 1993; 150:710.</a></li><li><a class="nounderline abstract_t">Filipsson S, Hultén L, Lindstedt G. Malabsorption of fat and vitamin B12 before and after intestinal resection for Crohn's disease. Scand J Gastroenterol 1978; 13:529.</a></li><li><a class="nounderline abstract_t">Thompson WG, Wrathell E. The relation between ileal resection and vitamin B12 absorption. Can J Surg 1977; 20:461.</a></li><li><a class="nounderline abstract_t">Koch MO, McDougal WS. Chlorpromazine: adjuvant therapy for the metabolic derangements created by urinary diversion through intestinal segments. J Urol 1985; 134:165.</a></li><li><a class="nounderline abstract_t">Boyd SD, Schiff WM, Skinner DG, et al. Prospective study of metabolic abnormalities in patient with continent Kock pouch urinary diversion. Urology 1989; 33:85.</a></li><li><a class="nounderline abstract_t">Koch MO, Gurevitch E, Hill DE, McDougal WS. Urinary solute transport by intestinal segments: a comparative study of ileum and colon in rats. J Urol 1990; 143:1275.</a></li><li><a class="nounderline abstract_t">Mills RD, Studer UE. Metabolic consequences of continent urinary diversion. J Urol 1999; 161:1057.</a></li><li><a class="nounderline abstract_t">Stampfer DS, McDougal WS, McGovern FJ. The use of in bowel urology. Metabolic and nutritional complications. Urol Clin North Am 1997; 24:715.</a></li><li><a class="nounderline abstract_t">McDougal WS, Stampfer DS, Kirley S, et al. Intestinal ammonium transport by ammonium and hydrogen exchange. J Am Coll Surg 1995; 181:241.</a></li><li><a class="nounderline abstract_t">Austin PF, DeLeary G, Homsy YL, et al. Long-term metabolic advantages of a gastrointestinal composite urinary reservoir. J Urol 1997; 158:1704.</a></li><li><a class="nounderline abstract_t">Lockhart JL, Davies R, Cox C, et al. The gastroileoileal pouch: an alternative continent urinary reservoir for patients with short bowel, acidosis and/or extensive pelvic radiation. J Urol 1993; 150:46.</a></li><li><a class="nounderline abstract_t">Ravi R, Dewan AK, Pandey KK. Transverse colon conduit urinary diversion in patients treated with very high dose pelvic irradiation. Br J Urol 1994; 73:51.</a></li><li><a class="nounderline abstract_t">Kato H, Igawa Y, Komiyama I, Nishizawa O. Continent urinary reservoir formation with transverse colon for patients with pelvic irradiation. Int J Urol 2002; 9:200.</a></li><li><a class="nounderline abstract_t">BRICKER EM. Bladder substitution after pelvic evisceration. Surg Clin North Am 1950; 30:1511.</a></li><li><a class="nounderline abstract_t">Madersbacher S, Schmidt J, Eberle JM, et al. Long-term outcome of ileal conduit diversion. J Urol 2003; 169:985.</a></li><li><a class="nounderline abstract_t">TURNBULL RB Jr. Intestinal stomas. Surg Clin North Am 1958; 38:1361.</a></li><li><a class="nounderline abstract_t">Farnham SB, Cookson MS. Surgical complications of urinary diversion. World J Urol 2004; 22:157.</a></li><li><a class="nounderline abstract_t">Kouba E, Sands M, Lentz A, et al. Incidence and risk factors of stomal complications in patients undergoing cystectomy with ileal conduit urinary diversion for bladder cancer. J Urol 2007; 178:950.</a></li><li><a class="nounderline abstract_t">Morales P, Golimbu M. Colonic urinary diversion: 10 years of experience. J Urol 1975; 113:302.</a></li><li><a class="nounderline abstract_t">Jahnson S, Pedersen J. Cystectomy and urinary diversion during twenty years--complications and metabolic implications. Eur Urol 1993; 24:343.</a></li><li><a class="nounderline abstract_t">Liu NW, Hackney JT, Gellhaus PT, et al. Incidence and risk factors of parastomal hernia in patients undergoing radical cystectomy and ileal conduit diversion. J Urol 2014; 191:1313.</a></li><li><a class="nounderline abstract_t">Donahue TF, Bochner BH, Sfakianos JP, et al. Risk factors for the development of parastomal hernia after radical cystectomy. J Urol 2014; 191:1708.</a></li><li><a class="nounderline abstract_t">Donahue TF, Bochner BH. Parastomal hernias after radical cystectomy and ileal conduit diversion. Investig Clin Urol 2016; 57:240.</a></li><li><a class="nounderline abstract_t">Liedberg F, Kollberg P, Allerbo M, et al. Preventing Parastomal Hernia After Ileal Conduit by the Use of a Prophylactic Mesh: A Randomised Study. Eur Urol 2020; 78:757.</a></li><li><a class="nounderline abstract_t">Donahue TF, Cha EK, Bochner BH. Rationale and Early Experience with Prophylactic Placement of Mesh to Prevent Parastomal Hernia Formation after Ileal Conduit Urinary Diversion and Cystectomy for Bladder Cancer. Curr Urol Rep 2016; 17:9.</a></li><li><a class="nounderline abstract_t">Movassaghi K, Shah SH, Cai J, et al. Incisional and Parastomal Hernia following Radical Cystectomy and Urinary Diversion: The University of Southern California Experience. J Urol 2016; 196:777.</a></li><li><a class="nounderline abstract_t">Bloch WE, Bejany DE, Penalver MA, Politano VA. Complications of the Miami pouch. J Urol 1992; 147:1017.</a></li><li><a class="nounderline abstract_t">Kock NG, Nilson AE, Nilsson LO, et al. Urinary diversion via a continent ileal reservoir: clinical results in 12 patients. J Urol 1982; 128:469.</a></li><li><a class="nounderline abstract_t">Rowland RG, Mitchell ME, Bihrle R, et al. Indiana continent urinary reservoir. J Urol 1987; 137:1136.</a></li><li><a class="nounderline abstract_t">Bochner BH, McCreath WA, Aubey JJ, et al. Use of an ureteroileocecal appendicostomy urinary reservoir in patients with recurrent pelvic malignancies treated with radiation. Gynecol Oncol 2004; 94:140.</a></li><li><a class="nounderline abstract_t">Mirhashemi R, Lamrbou N, Hus N, et al. The gastrointestinal complications of the Miami Pouch: a review of 77 cases. Gynecol Oncol 2004; 92:220.</a></li><li><a class="nounderline abstract_t">Angioli R, Estape R, Cantuaria G, et al. Urinary complications of Miami pouch: trend of conservative management. Am J Obstet Gynecol 1998; 179:343.</a></li><li><a class="nounderline abstract_t">Bochner BH, Karanikolas N, Barakat RR, et al. Ureteroileocecal appendicostomy based urinary reservoir in irradiated and nonirradiated patients. J Urol 2009; 182:2376.</a></li><li><a class="nounderline abstract_t">Sumfest JM, Burns MW, Mitchell ME. The Mitrofanoff principle in urinary reconstruction. J Urol 1993; 150:1875.</a></li><li><a class="nounderline abstract_t">Bihrle R. The Indiana pouch continent urinary reservoir. Urol Clin North Am 1997; 24:773.</a></li><li><a class="nounderline abstract_t">Holmes DG, Thrasher JB, Park GY, et al. Long-term complications related to the modified Indiana pouch. Urology 2002; 60:603.</a></li><li><a class="nounderline abstract_t">Killeen KP, Libertino JA. Management of bowel and urinary tract complications after urinary diversion. Urol Clin North Am 1988; 15:183.</a></li><li><a class="nounderline abstract_t">Parekh DJ, Gilbert WB, Koch MO, Smith JA Jr. Continent urinary reconstruction versus ileal conduit: a contemporary single-institution comparison of perioperative morbidity and mortality. Urology 2000; 55:852.</a></li><li><a class="nounderline abstract_t">Webster C, Bukkapatnam R, Seigne JD, et al. Continent colonic urinary reservoir (Florida pouch): long-term surgical complications (greater than 11 years). J Urol 2003; 169:174.</a></li><li><a class="nounderline abstract_t">Gschwend JE. Bladder substitution. Curr Opin Urol 2003; 13:477.</a></li><li><a class="nounderline abstract_t">Sullivan JW, Grabstald H, Whitmore WF Jr. Complications of ureteroileal conduit with radical cystectomy: review of 336 cases. J Urol 1980; 124:797.</a></li><li><a class="nounderline abstract_t">Middleton AW Jr, Hendren WH. Ileal conduits in children at the Massachusetts General Hospital from 1955 to 1970. J Urol 1976; 115:591.</a></li><li><a class="nounderline abstract_t">Richie JP, Skinner DG, Waisman J. The effect of reflux on the development of pyelonephritis in urinary diversion: an experimental study. J Surg Res 1974; 16:256.</a></li><li><a class="nounderline abstract_t">Steven K, Poulsen AL. The orthotopic Kock ileal neobladder: functional results, urodynamic features, complications and survival in 166 men. J Urol 2000; 164:288.</a></li><li><a class="nounderline abstract_t">Studer UE, Danuser H, Thalmann GN, et al. Antireflux nipples or afferent tubular segments in 70 patients with ileal low pressure bladder substitutes: long-term results of a prospective randomized trial. J Urol 1996; 156:1913.</a></li><li><a class="nounderline abstract_t">Boxer RJ, Fritzsche P, Skinner DG, et al. Replacement of the ureter by small intestine: clinical application and results of the ileal ureter in 89 patients. J Urol 1979; 121:728.</a></li><li><a class="nounderline abstract_t">Pantuck AJ, Han KR, Perrotti M, et al. Ureteroenteric anastomosis in continent urinary diversion: long-term results and complications of direct versus nonrefluxing techniques. J Urol 2000; 163:450.</a></li><li><a class="nounderline abstract_t">Shaaban AA, Abdel-Latif M, Mosbah A, et al. A randomized study comparing an antireflux system with a direct ureteric anastomosis in patients with orthotopic ileal neobladders. BJU Int 2006; 97:1057.</a></li><li><a class="nounderline abstract_t">Stenzl A, Höltl L. Orthotopic bladder reconstruction in women--what we have learned over the last decade. Crit Rev Oncol Hematol 2003; 47:147.</a></li><li><a class="nounderline abstract_t">Steers WD. Voiding dysfunction in the orthotopic neobladder. World J Urol 2000; 18:330.</a></li><li><a class="nounderline abstract_t">Hautmann RE. Urinary diversion: ileal conduit to neobladder. J Urol 2003; 169:834.</a></li><li><a class="nounderline abstract_t">Varol C, Studer UE. Managing patients after an ileal orthotopic bladder substitution. BJU Int 2004; 93:266.</a></li><li><a class="nounderline abstract_t">Hautmann RE, de Petriconi R, Gottfried HW, et al. The ileal neobladder: complications and functional results in 363 patients after 11 years of followup. J Urol 1999; 161:422.</a></li><li><a class="nounderline abstract_t">Studer UE, Danuser H, Hochreiter W, et al. Summary of 10 years' experience with an ileal low-pressure bladder substitute combined with an afferent tubular isoperistaltic segment. World J Urol 1996; 14:29.</a></li><li><a class="nounderline abstract_t">Lee KS, Montie JE, Dunn RL, Lee CT. Hautmann and Studer orthotopic neobladders: a contemporary experience. J Urol 2003; 169:2188.</a></li><li><a class="nounderline abstract_t">Stein JP, Lieskovsky G, Ginsberg DA, et al. The T pouch: an orthotopic ileal neobladder incorporating a serosal lined ileal antireflux technique. J Urol 1998; 159:1836.</a></li><li><a class="nounderline abstract_t">Bedük Y, Türkölmez K, Baltaci S, Göğüş C. Comparison of clinical and urodynamic outcome in orthotopic ileocaecal and ileal neobladder. Eur Urol 2003; 43:258.</a></li><li><a class="nounderline abstract_t">Studer UE, Burkhard FC, Schumacher M, et al. Twenty years experience with an ileal orthotopic low pressure bladder substitute--lessons to be learned. J Urol 2006; 176:161.</a></li><li><a class="nounderline abstract_t">Stein JP, Dunn MD, Quek ML, et al. The orthotopic T pouch ileal neobladder: experience with 209 patients. J Urol 2004; 172:584.</a></li><li><a class="nounderline abstract_t">Ali-el-Dein B, el-Sobky E, Hohenfellner M, Ghoneim MA. Orthotopic bladder substitution in women: functional evaluation. J Urol 1999; 161:1875.</a></li><li><a class="nounderline abstract_t">Stenzl A, Jarolim L, Coloby P, et al. Urethra-sparing cystectomy and orthotopic urinary diversion in women with malignant pelvic tumors. Cancer 2001; 92:1864.</a></li><li><a class="nounderline abstract_t">Hautmann RE, de Petriconi R, Kleinschmidt K, et al. Orthotopic ileal neobladder in females: impact of the urethral resection line on functional results. Int Urogynecol J Pelvic Floor Dysfunct 2000; 11:224.</a></li><li><a class="nounderline abstract_t">Arai Y, Okubo K, Konami T, et al. Voiding function of orthotopic ileal neobladder in women. Urology 1999; 54:44.</a></li><li><a class="nounderline abstract_t">Stein JP, Penson DF, Lee C, et al. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer. J Urol 2009; 181:2052.</a></li><li><a class="nounderline abstract_t">Simon J, Bartsch G Jr, Küfer R, et al. Neobladder emptying failure in males: incidence, etiology and therapeutic options. J Urol 2006; 176:1468.</a></li><li><a class="nounderline abstract_t">Stenzl A, Colleselli K, Poisel S, et al. The use of neobladders in women undergoing cystectomy for transitional-cell cancer. World J Urol 1996; 14:15.</a></li><li><a class="nounderline abstract_t">Imbimbo C, Mirone V, Siracusano S, et al. Quality of Life Assessment With Orthotopic Ileal Neobladder Reconstruction After Radical Cystectomy: Results From a Prospective Italian Multicenter Observational Study. Urology 2015; 86:974.</a></li><li><a class="nounderline abstract_t">Clements MB, Atkinson TM, Dalbagni GM, et al. Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort. Eur Urol 2022; 81:294.</a></li><li><a class="nounderline abstract_t">Dutta SC, Chang SC, Coffey CS, et al. Health related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder. J Urol 2002; 168:164.</a></li><li><a class="nounderline abstract_t">Hobisch A, Tosun K, Kinzl J, et al. Quality of life after cystectomy and orthotopic neobladder versus ileal conduit urinary diversion. World J Urol 2000; 18:338.</a></li><li><a class="nounderline abstract_t">Smith JA. The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a difference? J Urol 2003; 170:331.</a></li><li><a class="nounderline abstract_t">Månsson A, Davidsson T, Hunt S, Månsson W. The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a difference? BJU Int 2002; 90:386.</a></li><li><a class="nounderline abstract_t">Henningsohn L, Steven K, Kallestrup EB, Steineck G. Distressful symptoms and well-being after radical cystectomy and orthotopic bladder substitution compared with a matched control population. J Urol 2002; 168:168.</a></li><li><a class="nounderline abstract_t">Porter MP, Penson DF. Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: a systematic review and critical analysis of the literature. J Urol 2005; 173:1318.</a></li><li><a class="nounderline abstract_t">Link RE, Lerner SP. Rebuilding the lower urinary tract after cystectomy: a roadmap for patient selection and counseling. Semin Urol Oncol 2001; 19:24.</a></li><li class="breakAll">Chang SS, Bochner BH, Chou R, et al. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline. J Urol 2017; 198: 552. Available at: http://www.auanet.org/guidelines/muscle-invasive-bladder-cancer-new-(2017) (Accessed on September 27, 2017).</li><li><a class="nounderline abstract_t">Siddiqui KM, Izawa JI. Ileal conduit: standard urinary diversion for elderly patients undergoing radical cystectomy. World J Urol 2016; 34:19.</a></li><li><a class="nounderline abstract_t">Lebret T, Hervé JM, Barré P, et al. Urethral recurrence of transitional cell carcinoma of the bladder. Predictive value of preoperative latero-montanal biopsies and urethral frozen sections during prostatocystectomy. Eur Urol 1998; 33:170.</a></li><li><a class="nounderline abstract_t">Hardeman SW, Soloway MS. Urethral recurrence following radical cystectomy. J Urol 1990; 144:666.</a></li><li><a class="nounderline abstract_t">Donat SM, Wei DC, McGuire MS, Herr HW. The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer. J Urol 2001; 165:1580.</a></li><li><a class="nounderline abstract_t">Kassouf W, Spiess PE, Brown GA, et al. Prostatic urethral biopsy has limited usefulness in counseling patients regarding final urethral margin status during orthotopic neobladder reconstruction. J Urol 2008; 180:164.</a></li><li><a class="nounderline abstract_t">von Rundstedt FC, Mata DA, Shen S, et al. Transurethral biopsy of the prostatic urethra is associated with final apical margin status at radical cystoprostatectomy. J Clin Urol 2016; 9:404.</a></li><li><a class="nounderline abstract_t">Freeman JA, Tarter TA, Esrig D, et al. Urethral recurrence in patients with orthotopic ileal neobladders. J Urol 1996; 156:1615.</a></li><li><a class="nounderline abstract_t">Stenzl A, Bartsch G, Rogatsch H. The remnant urothelium after reconstructive bladder surgery. Eur Urol 2002; 41:124.</a></li><li><a class="nounderline abstract_t">Stein JP, Esrig D, Freeman JA, et al. Prospective pathologic analysis of female cystectomy specimens: risk factors for orthotopic diversion in women. Urology 1998; 51:951.</a></li><li><a class="nounderline abstract_t">Stenzl A, Colleselli K, Poisel S, et al. Anterior exenteration with subsequent ureteroileal urethrostomy in females. Anatomy, risk of urethral recurrence, surgical technique, and results. Eur Urol 1998; 33 Suppl 4:18.</a></li><li><a class="nounderline abstract_t">Maralani S, Wood DP Jr, Grignon D, et al. Incidence of urethral involvement in female bladder cancer: an anatomic pathologic study. Urology 1997; 50:537.</a></li><li><a class="nounderline abstract_t">Miura H, Hatakeyama S, Tanaka T, et al. Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction. Urol Oncol 2023; 41:254.e17.</a></li><li><a class="nounderline abstract_t">Hautmann RE, Simon J. Ileal neobladder and local recurrence of bladder cancer: patterns of failure and impact on function in men. J Urol 1999; 162:1963.</a></li><li><a class="nounderline abstract_t">Srinivas S, Mahalati K, Freiha FS. Methotrexate tolerance in patients with ileal conduits and continent diversions. Cancer 1998; 82:1134.</a></li><li><a class="nounderline abstract_t">Bulbul MA, Wazzan W, Farhat W, et al. Feasibility of radiation and chemotherapy following cystectomy and orthotopic neobladder for invasive bladder cancer. Can J Urol 1998; 5:469.</a></li><li><a class="nounderline abstract_t">Millikan R, Dinney C, Swanson D, et al. Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. J Clin Oncol 2001; 19:4005.</a></li><li><a class="nounderline abstract_t">Leow JJ, Reese SW, Jiang W, et al. Propensity-matched comparison of morbidity and costs of open and robot-assisted radical cystectomies: a contemporary population-based analysis in the United States. Eur Urol 2014; 66:569.</a></li><li><a class="nounderline abstract_t">Hanna N, Leow JJ, Sun M, et al. Comparative effectiveness of robot-assisted vs. open radical cystectomy. Urol Oncol 2018; 36:88.e1.</a></li><li><a class="nounderline abstract_t">Zamboni S, Soria F, Mathieu R, et al. Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration. BJU Int 2019; 124:656.</a></li><li><a class="nounderline abstract_t">Parekh DJ, Reis IM, Castle EP, et al. Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet 2018; 391:2525.</a></li><li><a class="nounderline abstract_t">Bochner BH, Sjoberg DD, Laudone VP, Memorial Sloan Kettering Cancer Center Bladder Cancer Surgical Trials Group. A randomized trial of robot-assisted laparoscopic radical cystectomy. N Engl J Med 2014; 371:389.</a></li><li><a class="nounderline abstract_t">Khan MS, Gan C, Ahmed K, et al. A Single-centre Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL). Eur Urol 2016; 69:613.</a></li><li><a class="nounderline abstract_t">Anderson CB, Morgan TM, Kappa S, et al. Ureteroenteric anastomotic strictures after radical cystectomy-does operative approach matter? J Urol 2013; 189:541.</a></li><li><a class="nounderline abstract_t">Goh AC, Belarmino A, Patel NA, et al. A Population-based Study of Ureteroenteric Strictures After Open and Robot-assisted Radical Cystectomy. Urology 2020; 135:57.</a></li><li><a class="nounderline abstract_t">Smith AB, Raynor M, Amling CL, et al. Multi-institutional analysis of robotic radical cystectomy for bladder cancer: perioperative outcomes and complications in 227 patients. J Laparoendosc Adv Surg Tech A 2012; 22:17.</a></li><li><a class="nounderline abstract_t">Catto JWF, Khetrapal P, Ricciardi F, et al. Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial. JAMA 2022; 327:2092.</a></li><li><a class="nounderline abstract_t">Hussein AA, May PR, Jing Z, et al. Outcomes of Intracorporeal Urinary Diversion after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. J Urol 2018; 199:1302.</a></li><li><a class="nounderline abstract_t">Goh AC, Gill IS, Lee DJ, et al. Robotic intracorporeal orthotopic ileal neobladder: replicating open surgical principles. Eur Urol 2012; 62:891.</a></li><li><a class="nounderline abstract_t">Goh AC, Aghazadeh MA, Krasnow RE, et al. Robotic Intracorporeal Continent Cutaneous Urinary Diversion: Primary Description. J Endourol 2015; 29:1217.</a></li><li><a class="nounderline abstract_t">Bochner BH, Dalbagni G, Sjoberg DD, et al. Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial. Eur Urol 2015; 67:1042.</a></li><li><a class="nounderline abstract_t">Bachour K, Faiena I, Salmasi A, et al. Trends in urinary diversion after radical cystectomy for urothelial carcinoma. World J Urol 2018; 36:409.</a></li><li><a class="nounderline abstract_t">Groeben C, Koch R, Baunacke M, et al. Urinary Diversion After Radical Cystectomy for Bladder Cancer: Comparing Trends in the US and Germany from 2006 to 2014. Ann Surg Oncol 2018; 25:3502.</a></li><li><a class="nounderline abstract_t">Smith JA Jr, Whitmore WF Jr. Salvage cystectomy for bladder cancer after failure of definitive irradiation. J Urol 1981; 125:643.</a></li><li><a class="nounderline abstract_t">Swanson DA, von Eschenbach AC, Bracken RB, Johnson DE. Salvage cystectomy for bladder carcinoma. Cancer 1981; 47:2275.</a></li><li><a class="nounderline abstract_t">Salom EM, Mendez LE, Schey D, et al. Continent ileocolonic urinary reservoir (Miami pouch): the University of Miami experience over 15 years. Am J Obstet Gynecol 2004; 190:994.</a></li><li><a class="nounderline abstract_t">Ahlering TE, Kanellos A, Boyd SD, et al. A comparative study of perioperative complications with Kock pouch urinary diversion in highly irradiated versus nonirradiated patients. J Urol 1988; 139:1202.</a></li><li><a class="nounderline abstract_t">Bochner BH, Figueroa AJ, Skinner EC, et al. Salvage radical cystoprostatectomy and orthotopic urinary diversion following radiation failure. J Urol 1998; 160:29.</a></li><li><a class="nounderline abstract_t">Segreti EM, Morris M, Levenback C, et al. Transverse colon urinary diversion in gynecologic oncology. Gynecol Oncol 1996; 63:66.</a></li><li><a class="nounderline abstract_t">Chang SS, Alberts GL, Smith JA Jr, Cookson MS. Ileal conduit urinary diversion in patients with previous history of abdominal/pelvic irradiation. World J Urol 2004; 22:272.</a></li><li><a class="nounderline abstract_t">Hautmann RE, de Petriconi R, Volkmer BG. Neobladder formation after pelvic irradiation. World J Urol 2009; 27:57.</a></li><li><a class="nounderline abstract_t">Gheiler EL, Wood DP Jr, Montie JE, Pontes JE. Orthotopic urinary diversion is a viable option in patients undergoing salvage cystoprostatectomy for recurrent prostate cancer after definitive radiation therapy. Urology 1997; 50:580.</a></li><li><a class="nounderline abstract_t">Wammack R, Wricke C, Hohenfellner R. Long-term results of ileocecal continent urinary diversion in patients treated with and without previous pelvic irradiation. J Urol 2002; 167:2058.</a></li><li><a class="nounderline abstract_t">van Savage JG, Slaughenhoupt BL. Approach to urinary diversion in the surgical patient. J Surg Oncol 2000; 73:33.</a></li><li><a class="nounderline abstract_t">Sogni F, Brausi M, Frea B, et al. Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer. Urology 2008; 71:919.</a></li><li><a class="nounderline abstract_t">Clark PE, Stein JP, Groshen SG, et al. Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients. Cancer 2005; 104:36.</a></li><li><a class="nounderline abstract_t">Lee CT, Dunn RL, Chen BT, et al. Impact of body mass index on radical cystectomy. J Urol 2004; 172:1281.</a></li><li><a class="nounderline abstract_t">Reyes MA, Nieder AM, Kava BR, et al. Does body mass index affect outcome after reconstruction of orthotopic neobladder? Urology 2007; 69:475.</a></li><li><a class="nounderline abstract_t">Perimenis P, Burkhard FC, Kessler TM, et al. Ileal orthotopic bladder substitute combined with an afferent tubular segment: long-term upper urinary tract changes and voiding pattern. Eur Urol 2004; 46:604.</a></li><li><a class="nounderline abstract_t">Shabsigh A, Korets R, Vora KC, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 2009; 55:164.</a></li><li><a class="nounderline abstract_t">Wullt B, Holst E, Steven K, et al. Microbial flora in ileal and colonic neobladders. Eur Urol 2004; 45:233.</a></li><li><a class="nounderline abstract_t">Wood DP Jr, Bianco FJ Jr, Pontes JE, et al. Incidence and significance of positive urine cultures in patients with an orthotopic neobladder. J Urol 2003; 169:2196.</a></li><li><a class="nounderline abstract_t">Zabell JR, Adejoro O, Konety BR, Weight CJ. Risk of end stage kidney disease after radical cystectomy according to urinary diversion type. J Urol 2015; 193:1283.</a></li><li><a class="nounderline abstract_t">Eisenberg MS, Thompson RH, Frank I, et al. Long-term renal function outcomes after radical cystectomy. J Urol 2014; 191:619.</a></li><li><a class="nounderline abstract_t">Gershman B, Eisenberg MS, Thompson RH, et al. Comparative impact of continent and incontinent urinary diversion on long-term renal function after radical cystectomy in patients with preoperative chronic kidney disease 2 and chronic kidney disease 3a. Int J Urol 2015; 22:651.</a></li><li><a class="nounderline abstract_t">Holmes DG, Park GY, Thrasher JB, et al. Incidence of cholelithiasis in 125 continent urinary diversions. J Urol 2001; 165:1897.</a></li><li><a class="nounderline abstract_t">Fujisawa M, Gotoh A, Nakamura I, et al. Long-term assessment of serum vitamin B(12) concentrations in patients with various types of orthotopic intestinal neobladder. Urology 2000; 56:236.</a></li><li><a class="nounderline abstract_t">Ganesan T, Khadra MH, Wallis J, Neal DE. Vitamin B12 malabsorption following bladder reconstruction or diversion with bowel segments. ANZ J Surg 2002; 72:479.</a></li><li><a class="nounderline abstract_t">Alcini E, D'Addessi A, Racioppi M, et al. Results of 4 years of experience with bladder replacement using an ileocecal segment with multiple transverse teniamyotomies. J Urol 1993; 149:735.</a></li><li><a class="nounderline abstract_t">Gupta A, Atoria CL, Ehdaie B, et al. Risk of fracture after radical cystectomy and urinary diversion for bladder cancer. J Clin Oncol 2014; 32:3291.</a></li><li><a class="nounderline abstract_t">Hossain M. The osteomalacia syndrome after colocystoplasty; a cure with sodium bicarbonate alone. Br J Urol 1970; 42:243.</a></li><li><a class="nounderline abstract_t">Siklos P, Davie M, Jung RT, Chalmers TM. Osteomalacia in ureterosigmoidostomy: healing by correction of the acidosis. Br J Urol 1980; 52:61.</a></li><li><a class="nounderline abstract_t">Perry W, Allen LN, Stamp TC, Walker PG. Vitamin D resistance in osteomalacia after ureterosigmoidostomy. N Engl J Med 1977; 297:1110.</a></li><li><a class="nounderline abstract_t">North AC, Lakshmanan Y. Malignancy associated with the use of intestinal segments in the urinary tract. Urol Oncol 2007; 25:165.</a></li><li><a class="nounderline abstract_t">Aragona F, De Caro R, Parenti A, et al. Structural and ultrastructural changes in ileal neobladder mucosa: a 7-year follow-up. Br J Urol 1998; 81:55.</a></li><li><a class="nounderline abstract_t">Austen M, Kälble T. Secondary malignancies in different forms of urinary diversion using isolated gut. J Urol 2004; 172:831.</a></li><li><a class="nounderline abstract_t">Ali-El-Dein B, El-Tabey N, Abdel-Latif M, et al. Late uro-ileal cancer after incorporation of ileum into the urinary tract. J Urol 2002; 167:84.</a></li><li><a class="nounderline abstract_t">Pickard R. Tumour formation within intestinal segments transposed to the urinary tract. World J Urol 2004; 22:227.</a></li><li><a class="nounderline abstract_t">Azimuddin K, Khubchandani IT, Stasik JJ, et al. Neoplasia after ureterosigmoidostomy. Dis Colon Rectum 1999; 42:1632.</a></li><li><a class="nounderline abstract_t">Fichtner J. Follow-up after urinary diversion. Urol Int 1999; 63:40.</a></li><li><a class="nounderline abstract_t">Desgrandchamps F, Cariou G, Barthelemy Y, et al. Spontaneous rupture of orthotopic detubularized ileal bladder replacement: report of 5 cases. J Urol 1997; 158:798.</a></li><li><a class="nounderline abstract_t">Hassan JM, Cookson MS, Smith JA Jr, Chang SS. Urethral recurrence in patients following orthotopic urinary diversion. J Urol 2004; 172:1338.</a></li><li><a class="nounderline abstract_t">Stein JP, Clark P, Miranda G, et al. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients. J Urol 2005; 173:1163.</a></li><li><a class="nounderline abstract_t">Clark PE, Stein JP, Groshen SG, et al. The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer. J Urol 2004; 172:1342.</a></li><li><a class="nounderline abstract_t">Yossepowitch O, Dalbagni G, Golijanin D, et al. Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence. J Urol 2003; 169:177.</a></li><li><a class="nounderline abstract_t">Huguet J, Palou J, Serrallach M, et al. Management of urethral recurrence in patients with Studer ileal neobladder. Eur Urol 2003; 43:495.</a></li><li><a class="nounderline abstract_t">Varol C, Thalmann GN, Burkhard FC, Studer UE. Treatment of urethral recurrence following radical cystectomy and ileal bladder substitution. J Urol 2004; 172:937.</a></li><li><a class="nounderline abstract_t">Nieder AM, Sved PD, Gomez P, et al. Urethral recurrence after cystoprostatectomy: implications for urinary diversion and monitoring. Urology 2004; 64:950.</a></li><li><a class="nounderline abstract_t">Yoshida K, Nishiyama H, Kinoshita H, et al. Surgical treatment for urethral recurrence after ileal neobladder reconstruction in patients with bladder cancer. BJU Int 2006; 98:1008.</a></li><li><a class="nounderline abstract_t">Freeman JA, Esrig D, Stein JP, Skinner DG. Management of the patient with bladder cancer. Urethral recurrence. Urol Clin North Am 1994; 21:645.</a></li><li><a class="nounderline abstract_t">Taylor JM, Spiess PE, Kassouf W, et al. Management of urethral recurrence after orthotopic urinary diversion. BJU Int 2010; 106:56.</a></li><li><a class="nounderline abstract_t">Levinson AK, Johnson DE, Wishnow KI. Indications for urethrectomy in an era of continent urinary diversion. J Urol 1990; 144:73.</a></li><li><a class="nounderline abstract_t">Tobisu K, Tanaka Y, Mizutani T, Kakizoe T. Transitional cell carcinoma of the urethra in men following cystectomy for bladder cancer: multivariate analysis for risk factors. J Urol 1991; 146:1551.</a></li><li><a class="nounderline abstract_t">Schellhammer PF, Whitmore WF Jr. Transitional cell carcinoma of the urethra in men having cystectomy for bladder cancer. J Urol 1976; 115:56.</a></li><li><a class="nounderline abstract_t">Herr HW, Donat SM, Bajorin DF. Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer. J Urol 2001; 165:811.</a></li><li><a class="nounderline abstract_t">Donat SM, Genega EM, Herr HW, Reuter VE. Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance. J Urol 2001; 165:1117.</a></li><li><a class="nounderline abstract_t">Pettus JA, Carver BS, Masterson T, et al. Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer. Urology 2009; 73:328.</a></li><li><a class="nounderline abstract_t">Akkad T, Gozzi C, Deibl M, et al. Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center. J Urol 2006; 175:1268.</a></li><li><a class="nounderline abstract_t">Bochner BH, Montie JE, Lee CT. Follow-up strategies and management of recurrence in urologic oncology bladder cancer: invasive bladder cancer. Urol Clin North Am 2003; 30:777.</a></li><li><a class="nounderline abstract_t">Knapik JA, Murphy WM. Urethral wash cytopathology for monitoring patients after cystoprostatectomy with urinary diversion. Cancer 2003; 99:352.</a></li><li><a class="nounderline abstract_t">Lin DW, Herr HW, Dalbagni G. Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy. J Urol 2003; 169:961.</a></li><li><a class="nounderline abstract_t">Van Poppel H, Sorgeloose T. Radical cystectomy with or without urethrectomy? Crit Rev Oncol Hematol 2003; 47:141.</a></li></ol></div><div id="topicVersionRevision">Topic 2958 Version 32.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11551125" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Urinary diversion in gynecologic oncology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10504669" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Pelvic exenteration for carcinoma of the colon and rectum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9120962" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Continent urinary diversion: the Children's Hospital experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14665893" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Local urethral recurrence after radical cystectomy and orthotopic bladder substitution in women: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3184289" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Gastrocystoplasty: an alternative solution to the problem of urological reconstruction in the severely compromised patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2241451" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Hyperammonemic encephalopathy in urinary diversion with urea-splitting urinary tract infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3520017" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Accurate determination of renal function in patients with intestinal urinary diversions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1856952" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Urease and the acidosis of urinary intestinal diversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1942308" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Mechanisms of solute transport following urinary diversion through intestinal segments: an experimental study with rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3944853" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Jejunal conduit urinary diversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7609133" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Hypergastrinemia, dysuria-hematuria and metabolic alkalosis: complications associated with gastrocystoplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8326629" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The syndrome of dysuria and hematuria in pediatric urinary reconstruction with stomach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8326630" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Metabolic complications of the use of stomach for urinary reconstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/705247" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Malabsorption of fat and vitamin B12 before and after intestinal resection for Crohn's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/890622" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The relation between ileal resection and vitamin B12 absorption.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2989565" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Chlorpromazine: adjuvant therapy for the metabolic derangements created by urinary diversion through intestinal segments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2916295" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Prospective study of metabolic abnormalities in patient with continent Kock pouch urinary diversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2342200" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Urinary solute transport by intestinal segments: a comparative study of ileum and colon in rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10081838" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Metabolic consequences of continent urinary diversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9391524" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The use of in bowel urology. Metabolic and nutritional complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7670684" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Intestinal ammonium transport by ammonium and hydrogen exchange.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9334583" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Long-term metabolic advantages of a gastrointestinal composite urinary reservoir.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8510273" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : The gastroileoileal pouch: an alternative continent urinary reservoir for patients with short bowel, acidosis and/or extensive pelvic radiation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8298899" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Transverse colon conduit urinary diversion in patients treated with very high dose pelvic irradiation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12010313" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Continent urinary reservoir formation with transverse colon for patients with pelvic irradiation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14782163" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Bladder substitution after pelvic evisceration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12576827" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Long-term outcome of ileal conduit diversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13592688" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Intestinal stomas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15316737" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Surgical complications of urinary diversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17632147" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Incidence and risk factors of stomal complications in patients undergoing cystectomy with ileal conduit urinary diversion for bladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1117495" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Colonic urinary diversion: 10 years of experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8262100" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Cystectomy and urinary diversion during twenty years--complications and metabolic implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24333109" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Incidence and risk factors of parastomal hernia in patients undergoing radical cystectomy and ileal conduit diversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24384155" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Risk factors for the development of parastomal hernia after radical cystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27437533" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Parastomal hernias after radical cystectomy and ileal conduit diversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32800407" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Preventing Parastomal Hernia After Ileal Conduit by the Use of a Prophylactic Mesh: A Randomised Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26757903" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Rationale and Early Experience with Prophylactic Placement of Mesh to Prevent Parastomal Hernia Formation after Ileal Conduit Urinary Diversion and Cystectomy for Bladder Cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27044570" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Incisional and Parastomal Hernia following Radical Cystectomy and Urinary Diversion: The University of Southern California Experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1552577" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Complications of the Miami pouch.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7120547" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Urinary diversion via a continent ileal reservoir: clinical results in 12 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3586143" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Indiana continent urinary reservoir.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15262132" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Use of an ureteroileocecal appendicostomy urinary reservoir in patients with recurrent pelvic malignancies treated with radiation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14751162" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : The gastrointestinal complications of the Miami Pouch: a review of 77 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9731836" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Urinary complications of Miami pouch: trend of conservative management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19762044" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Ureteroileocecal appendicostomy based urinary reservoir in irradiated and nonirradiated patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8230523" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : The Mitrofanoff principle in urinary reconstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9391530" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : The Indiana pouch continent urinary reservoir.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12385916" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Long-term complications related to the modified Indiana pouch.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3289227" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Management of bowel and urinary tract complications after urinary diversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10840090" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Continent urinary reconstruction versus ileal conduit: a contemporary single-institution comparison of perioperative morbidity and mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12478129" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Continent colonic urinary reservoir (Florida pouch): long-term surgical complications (greater than 11 years).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14560142" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Bladder substitution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7441828" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Complications of ureteroileal conduit with radical cystectomy: review of 336 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1271557" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Ileal conduits in children at the Massachusetts General Hospital from 1955 to 1970.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4819613" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : The effect of reflux on the development of pyelonephritis in urinary diversion: an experimental study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10893568" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : The orthotopic Kock ileal neobladder: functional results, urodynamic features, complications and survival in 166 men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8911354" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Antireflux nipples or afferent tubular segments in 70 patients with ileal low pressure bladder substitutes: long-term results of a prospective randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/458942" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Replacement of the ureter by small intestine: clinical application and results of the ileal ureter in 89 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10647652" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Ureteroenteric anastomosis in continent urinary diversion: long-term results and complications of direct versus nonrefluxing techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16643492" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : A randomized study comparing an antireflux system with a direct ureteric anastomosis in patients with orthotopic ileal neobladders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12900008" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Orthotopic bladder reconstruction in women--what we have learned over the last decade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11131310" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Voiding dysfunction in the orthotopic neobladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12576795" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Urinary diversion: ileal conduit to neobladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14764120" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Managing patients after an ileal orthotopic bladder substitution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9915417" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : The ileal neobladder: complications and functional results in 363 patients after 11 years of followup.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8646238" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Summary of 10 years' experience with an ileal low-pressure bladder substitute combined with an afferent tubular isoperistaltic segment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12771746" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Hautmann and Studer orthotopic neobladders: a contemporary experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9598471" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : The T pouch: an orthotopic ileal neobladder incorporating a serosal lined ileal antireflux technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12600428" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Comparison of clinical and urodynamic outcome in orthotopic ileocaecal and ileal neobladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16753394" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Twenty years experience with an ileal orthotopic low pressure bladder substitute--lessons to be learned.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15247737" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : The orthotopic T pouch ileal neobladder: experience with 209 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10332457" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Orthotopic bladder substitution in women: functional evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11745259" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Urethra-sparing cystectomy and orthotopic urinary diversion in women with malignant pelvic tumors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11005474" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Orthotopic ileal neobladder in females: impact of the urethral resection line on functional results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10414725" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Voiding function of orthotopic ileal neobladder in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19286213" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16952662" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Neobladder emptying failure in males: incidence, etiology and therapeutic options.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8646235" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : The use of neobladders in women undergoing cystectomy for transitional-cell cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26291562" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Quality of Life Assessment With Orthotopic Ileal Neobladder Reconstruction After Radical Cystectomy: Results From a Prospective Italian Multicenter Observational Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34629182" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12050514" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Health related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11131311" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Quality of life after cystectomy and orthotopic neobladder versus ileal conduit urinary diversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14567332" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a difference?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12175394" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a difference?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12050515" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Distressful symptoms and well-being after radical cystectomy and orthotopic bladder substitution compared with a matched control population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15758789" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: a systematic review and critical analysis of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11246731" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Rebuilding the lower urinary tract after cystectomy: a roadmap for patient selection and counseling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11246731" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Rebuilding the lower urinary tract after cystectomy: a roadmap for patient selection and counseling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26475274" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Ileal conduit: standard urinary diversion for elderly patients undergoing radical cystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9519359" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Urethral recurrence of transitional cell carcinoma of the bladder. Predictive value of preoperative latero-montanal biopsies and urethral frozen sections during prostatocystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2388323" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Urethral recurrence following radical cystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11342921" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18485384" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Prostatic urethral biopsy has limited usefulness in counseling patients regarding final urethral margin status during orthotopic neobladder reconstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27818773" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Transurethral biopsy of the prostatic urethra is associated with final apical margin status at radical cystoprostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8863551" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Urethral recurrence in patients with orthotopic ileal neobladders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12074398" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : The remnant urothelium after reconstructive bladder surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9609632" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Prospective pathologic analysis of female cystectomy specimens: risk factors for orthotopic diversion in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9615203" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Anterior exenteration with subsequent ureteroileal urethrostomy in females. Anatomy, risk of urethral recurrence, surgical technique, and results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9338728" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Incidence of urethral involvement in female bladder cancer: an anatomic pathologic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36513564" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10569548" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Ileal neobladder and local recurrence of bladder cancer: patterns of failure and impact on function in men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9506360" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Methotrexate tolerance in patients with ileal conduits and continent diversions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11299103" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Feasibility of radiation and chemotherapy following cystectomy and orthotopic neobladder for invasive bladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11600601" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24491306" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Propensity-matched comparison of morbidity and costs of open and robot-assisted radical cystectomies: a contemporary population-based analysis in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29277584" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Comparative effectiveness of robot-assisted vs. open radical cystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31055865" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29976469" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25054732" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : A randomized trial of robot-assisted laparoscopic radical cystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26272237" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : A Single-centre Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23260561" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Ureteroenteric anastomotic strictures after radical cystectomy-does operative approach matter?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31618656" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : A Population-based Study of Ureteroenteric Strictures After Open and Robot-assisted Radical Cystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22142028" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Multi-institutional analysis of robotic radical cystectomy for bladder cancer: perioperative outcomes and complications in 227 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35569079" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29275112" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Outcomes of Intracorporeal Urinary Diversion after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22920581" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Robotic intracorporeal orthotopic ileal neobladder: replicating open surgical principles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25556514" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Robotic Intracorporeal Continent Cutaneous Urinary Diversion: Primary Description.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25496767" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29299664" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Trends in urinary diversion after radical cystectomy for urothelial carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29468604" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Urinary Diversion After Radical Cystectomy for Bladder Cancer: Comparing Trends in the US and Germany from 2006 to 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6785453" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Salvage cystectomy for bladder cancer after failure of definitive irradiation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7226122" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Salvage cystectomy for bladder carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15118628" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Continent ileocolonic urinary reservoir (Miami pouch): the University of Miami experience over 15 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3373587" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : A comparative study of perioperative complications with Kock pouch urinary diversion in highly irradiated versus nonirradiated patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9628599" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Salvage radical cystoprostatectomy and orthotopic urinary diversion following radiation failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8898171" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Transverse colon urinary diversion in gynecologic oncology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15448995" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Ileal conduit urinary diversion in patients with previous history of abdominal/pelvic irradiation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19020883" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Neobladder formation after pelvic irradiation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9338735" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Orthotopic urinary diversion is a viable option in patients undergoing salvage cystoprostatectomy for recurrent prostate cancer after definitive radiation therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11956438" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Long-term results of ileocecal continent urinary diversion in patients treated with and without previous pelvic irradiation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10649278" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Approach to urinary diversion in the surgical patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18355900" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15912515" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15371824" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Impact of body mass index on radical cystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17382148" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Does body mass index affect outcome after reconstruction of orthotopic neobladder?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15474270" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Ileal orthotopic bladder substitute combined with an afferent tubular segment: long-term upper urinary tract changes and voiding pattern.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18675501" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14734012" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Microbial flora in ileal and colonic neobladders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12771748" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Incidence and significance of positive urine cultures in patients with an orthotopic neobladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25444986" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Risk of end stage kidney disease after radical cystectomy according to urinary diversion type.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24036234" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Long-term renal function outcomes after radical cystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25881721" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Comparative impact of continent and incontinent urinary diversion on long-term renal function after radical cystectomy in patients with preoperative chronic kidney disease 2 and chronic kidney disease 3a.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11371876" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Incidence of cholelithiasis in 125 continent urinary diversions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10925085" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Long-term assessment of serum vitamin B(12) concentrations in patients with various types of orthotopic intestinal neobladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12123505" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Vitamin B12 malabsorption following bladder reconstruction or diversion with bowel segments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8455233" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : Results of 4 years of experience with bladder replacement using an ileocecal segment with multiple transverse teniamyotomies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25185104" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : Risk of fracture after radical cystectomy and urinary diversion for bladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5420165" id="rid147" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>148 : The osteomalacia syndrome after colocystoplasty; a cure with sodium bicarbonate alone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7426953" id="rid148" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>149 : Osteomalacia in ureterosigmoidostomy: healing by correction of the acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/909567" id="rid149" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>150 : Vitamin D resistance in osteomalacia after ureterosigmoidostomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17349534" id="rid150" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>151 : Malignancy associated with the use of intestinal segments in the urinary tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9467477" id="rid151" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>152 : Structural and ultrastructural changes in ileal neobladder mucosa: a 7-year follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15310979" id="rid152" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>153 : Secondary malignancies in different forms of urinary diversion using isolated gut.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11743281" id="rid153" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>154 : Late uro-ileal cancer after incorporation of ileum into the urinary tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15316739" id="rid154" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>155 : Tumour formation within intestinal segments transposed to the urinary tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10613486" id="rid155" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>156 : Neoplasia after ureterosigmoidostomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10592489" id="rid156" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>157 : Follow-up after urinary diversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9258085" id="rid157" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>158 : Spontaneous rupture of orthotopic detubularized ileal bladder replacement: report of 5 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15371836" id="rid158" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>159 : Urethral recurrence in patients following orthotopic urinary diversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15758728" id="rid159" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>160 : Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15371837" id="rid160" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>161 : The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12478130" id="rid161" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>162 : Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12705993" id="rid162" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>163 : Management of urethral recurrence in patients with Studer ileal neobladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15311003" id="rid163" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>164 : Treatment of urethral recurrence following radical cystectomy and ileal bladder substitution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15533484" id="rid164" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>165 : Urethral recurrence after cystoprostatectomy: implications for urinary diversion and monitoring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17034603" id="rid165" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>166 : Surgical treatment for urethral recurrence after ileal neobladder reconstruction in patients with bladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7974896" id="rid166" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>167 : Management of the patient with bladder cancer. Urethral recurrence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20002676" id="rid167" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>168 : Management of urethral recurrence after orthotopic urinary diversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2359182" id="rid168" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>169 : Indications for urethrectomy in an era of continent urinary diversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1942339" id="rid169" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>170 : Transitional cell carcinoma of the urethra in men following cystectomy for bladder cancer: multivariate analysis for risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1246114" id="rid170" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>171 : Transitional cell carcinoma of the urethra in men having cystectomy for bladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11176475" id="rid171" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>172 : Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11257650" id="rid172" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>173 : Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19022490" id="rid173" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>174 : Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16515977" id="rid174" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>175 : Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14680314" id="rid175" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>176 : Follow-up strategies and management of recurrence in urologic oncology bladder cancer: invasive bladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14681943" id="rid176" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>177 : Urethral wash cytopathology for monitoring patients after cystoprostatectomy with urinary diversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12576822" id="rid177" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>178 : Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12900007" id="rid178" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>179 : Radical cystectomy with or without urethrectomy?</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
